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We have previously shown that regenerated cutaneous afferents exhibit sensitization.  These 
changes were correlated with increased expression of neurotrophic factors in the affected skin, 
and receptors and ion channels in the dorsal root ganglia (DRG).  Here we found that saphenous 
nerve injury resulted in similar alterations in gene expression in the skin innervated by the 
uninjured contralateral saphenous nerve.  Several Nerve Growth Factor (NGF) and GDNF 
ligands were upregulated in the dorsal hindpaw hairy skin 7-21 days following contralateral 
saphenous nerve axotomy.  This increase in expression was correlated with upregulation of 
several receptors and ion channels in the L2,3 DRGs, including GFRα1, nucleotide receptors 
P2X3, P2Y1, and P2Y2, heat transducing channel TRPV1, and acid-sensing ion channels 1 
(ASIC1) and 3 (ASIC3).  Characterization of intact saphenous afferent fibers revealed that 4-5 
weeks after contralateral injury, C-polymodal population had significantly reduced heat 
thresholds.  There was also a significant increase in the proportion of mechanically insensitive-
heat sensitive (CH) neurons.  These findings provide evidence of peripheral mechanisms that 
may be involved in the development of mirror-image pain, a clinical phenomenon in which 
patients experience pain in the healthy region of the body contralateral to the injury site. 
The changes in the response properties of intact afferents at 4-5 weeks following 
contralateral injury were correlated with upregulation of P2Y1 and TRPV1 in the DRGs at 28d 
post-injury, and we investigated the role of these two targets in the functional plasticity observed 
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by utilizing an in vivo small interfering RNA (siRNA)-mediated knockdown strategy to target 
the upregulation of P2Y1 and TRPV1 in the L2,3 DRGs at 28 days following contralateral 
injury.  We found that blocking P2Y1 upregulation prevented the heat threshold reduction in C-
polymodal afferents and conclude that P2Y1 plays a critical role in the heat sensitivity of these 
fibers.  We then found that blocking the upregulation of TRPV1 blocked the recruitment of C-
heat fibers.  Taken together, our findings suggest that chronic exposure of intact cutaneous 
sensory neurons to increased endogenous levels of neurotrophic factors results in upregulation of 
target receptors and ion channels in the DRG and sensitization and phenotypic changes in intact 
sensory neurons. 
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1.0  INTRODUCTION 
Sensory neurons are defined as those neurons that detect stimuli from either the external or 
internal environment and transmit this information to the CNS.  Sensory input from the body and 
head is transmitted from the periphery by neurons located in dorsal root (DRG) and trigeminal 
ganglia (TG), respectively.  These pseudounipolar neurons contain a peripheral process that 
innervates the target (skin, tongue, face, etc.) and a central process that synapses on second order 
neurons in the superficial dorsal horn of the spinal cord (or analogous area in the brainstem for 
TG neurons).   
Among sensory neurons, specialized populations that can detect noxious thermal, 
chemical and mechanical stimuli are called nociceptors.  Nociceptors can be activated by intense 
stimuli that are potentially damaging or damaging (noxious) to the tissues and are generally 
thought not to be activated by innocuous stimuli such as warming or touching, although wide-
dynamic range nociceptors have been described in the viscera (Mayer and Gebhart, 1994; Traub 
et al., 1994) and may exist elsewhere. The consensus is that nociceptors are best distinguished by 
their function, and specifically by their relatively high threshold for activation, regardless of the 
specific stimuli to which they respond (e.g. mechanical or thermal).  Among primary afferents, 
nociceptors are primarily small diameter unmyelinated C-fibers and lightly myelinated Aδ fibers, 
although some Aβ fibers also function as nociceptors (Djouhri and Lawson, 2004).  These 
specialized sensory neurons typically serve a protective function to prevent tissue injury when 
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noxious stimuli are encountered (e.g. when tissue is being burned by accidentally touching a 
scalding hot stove). 
1.1 ANATOMY OF PRIMARY SENSORY NEURONS 
Sensory neuron cell bodies are located in spinal ganglia at every vertebral level as well as in 
association with cranial nerves V (trigeminal), VII (facial nerve), VIII (vestibulocochlear), IX 
(glossopharyngeal), and X (vagus).  At all vertebral levels the spinal ganglia or DRG are located 
on the dorsal root. Sensory neurons innervate two types of targets: somatic targets (skin, skeletal 
muscle and bones) and visceral targets (the inner organs).  The peripheral endings of somatic 
nociceptors are thought to be free nerve endings, which are unencapsulated and unspecialized 
nerve endings.  Free nerve endings are most frequently found in the skin and they penetrate the 
epidermis and end in the stratum granulosum.  
Cutaneous sensory neurons are usually divided on the basis of the conduction velocity 
(CV) of their axons into C-, Aδ-, and Aβ-fibers (Light et al., 1993).  C-fibers are unmyelinated 
and slow conducting afferents (CV <1m/s in mouse), whereas Aδ-fibers (CV<1-10 m/s mouse, 
<30m/s primates) are lightly myelinated, and Aβ-fibers (CV>10 m/s rodents, >30m/s primates) 
are heavily myelinated.  Nociceptors are found in all classes of sensory neurons.  However, as 
discussed above, it should be noted that in some mammals, over 50% of A-fibers can detect 
nociceptive stimuli (Djouhri and Lawson, 2004).  
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1.2 MOLECULAR PHENOTYPE OF SENSORY NEURONS 
Nociceptors are an inherently heterogeneous population.  They express a wide array of receptors, 
neurotransmitters, and other markers. In addition to being divided into three types by their CV, 
nociceptors are also classified as “peptidergic” and “non-peptidergic,” based on the content of 
peptides such as CGRP and Substance P (SP).  This distinction applies primarily to C-fiber 
nociceptors, although peptides are also expressed in some A-fiber nociceptors.  The non-
peptidergic neurons are identified based on their expression of specific gangliosides that bind 
IB4.  This distinction is useful for characterizing nociceptors because, in general, these two 
classes of neurons have different central and peripheral projections, growth factor dependencies, 
and different expression of other nociceptor-specific proteins (Snider and McMahon, 1998; Braz 
et al., 2005; Zylka et al., 2005; Chen et al., 2006). Non-peptidergic sensory neurons, labeled by 
IB4-binding, represent 41% of DRG neurons in rat (Bennett et al., 1998) and 32.5% in mice 
(Zwick et al., 2002), whereas 40% of DRG neurons in rat are CGRP-positive peptidergic sensory 
neurons (Bennett et al., 1998). During perinatal and postnatal periods, the IB4-binding non-
peptidergic neurons down-regulate the trkA receptor for NGF and begin to express Ret, the 
canonical kinase mediating the function of GFLs (Bennett et al., 1996; Molliver et al., 1997).  
These two classes of nociceptors also express different nociceptive markers. In mice, transient 
receptor potential cation channel subfamily Vanilloid member 1 (TRPV1) is mainly expressed in 
IB4-negative, peptidergic neurons (Zwick et al., 2002; Woodbury et al., 2004; Lawson et al., 
2008), whereas the majority of non-peptidergic neurons bind IB4 and express the ATP receptor 
P2X3 (Lindfors et al., 2006).  Other members of the TRP channel family also expressed in 
sensory neurons include TRP melastratin-8 (TRPM8) and TRPA1, both of which have been 
proposed to play a role in cool/cold detection. TRPM8 is activated by menthol and cool stimuli 
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(<23-28C), whereas TRPA1 responds to natural compounds such as mustard and cinnamon 
oils and responds to colder temperatures in heterologous systems (<18C). More detail of TRP 
channel expression in sensory neurons will be discussed later. 
1.3 SENSORY NEURON PLASTICITY 
Why is it important to study the behavior of primary afferents and the molecular mechanisms 
that may govern their biophysical properties?  While the relative contributions of peripheral vs. 
central mechanisms leading to sensitized pain circuits is complex, without primary afferent input, 
persistent pain states are rarely initiated (Cao et al., 1998; Laursen et al., 1999). Thus, in recent 
years many studies have examined the molecular changes in the primary afferents and their 
innervated tissues that might drive sensory neurons plasticity.   
The signaling of target-derived growth factors such as the neurotrophin (NGF) and glial 
cell line-derived neurotrophic factor (GDNF) families has been implicated in this sensitization 
process.  Previous studies have shown that constitutive overexpression of neurotrophic factors 
such as NGF, GDNF, Neurotrophin-3 (NT3), and artemin can alter the sensitivity of nociceptors 
and that this may be mediated by enhanced expression of associated ion channels and receptors 
in the DRGs (Stucky et al., 1999; Albers et al., 2006; Elitt et al., 2006; McIlwrath et al., 2007; 
Lawson et al., 2008). For example, it has been shown that overexpression of cutaneous artemin 
altered the levels of GFRα3 and TRPV1 in the DRGs and cutaneous nociceptor function (Elitt et 
al., 2006).  Similarly, overexpression of GDNF resulted in changes in the response properties of 
IB4-binding fibers responding to mechanical and thermal stimuli (Albers et al., 2006).  Likewise, 
following saphenous nerve axotomy, cutaneous expression of several trophic factors, including 
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neurotrophins such as NGF and NT-4/5, as well as neurotrophic factors such as GDNF and 
Artemin, was increased in the denervated skin (Jankowski et al. 2009a).   
Several studies have also provided evidence of injury-induced changes in DRG 
expression of several growth factor receptors and ion channels implicated in plasticity of primary 
afferents as well.  For example, peripheral nerve injury is known to induce changes in 
neuropeptides such as Substance P (Bisby and Kee, 1986; Ruocco et al., 2000), GFL receptors 
such as GFRα1 (Kury et al., 2001); trkA (Taniuchi et al., 1986), G-protein coupled receptors 
such as P2Y1 (Xiao et al., 2002), and voltage-gated ion channels (Ishikawa et al., 1999; Kim et 
al., 2001; Decosterd et al., 2002) in the DRGs.  Axotomy also increased the total number of 
GFRα3-positive neurons in the DRG (Orozco et al., 2001).  The GFRα receptors for GFLs are 
known to be differentially regulated within sensory neurons after sciatic nerve injury.  The 
percentage of neurons that express GFRα2 is markedly reduced, whereas those of GFRα1 and 
GFRα3 are increased (Bennett et al., 2000).  Such a phenotypic switch of injured DRG neurons 
may have functional implication in the generation of neuropathic pain.  In recent studies, we 
found similar changes in several of the same ion channels and receptors in the DRGs following 
saphenous nerve axotomy, including GFRα1, GFRα3, TRPV1, TRPV2, ASIC2a, ASIC3, P2X3, 
P2Y1, and P2Y2 (Jankowski et al. 2009a).   More recently, we showed that increased levels of 
artemin, GFRα3, and TRPV1 regulate phenotypic change in cutaneous sensory neurons 
following nerve axotomy and regeneration (Jankowski et al., 2010, 2012).  Determining whether 
these types of changes also occur in the DRGs of intact nerves exposed to increased neurotrophic 
factor levels would reveal whether the changes are growth factor-mediated or specific to injured 
neurons.   
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Inflammation is also known to evoke functional plasticity.  A broad range of 
inflammatory mediators, including growth factors, ATP, chemokines, cytokines, and protons can 
sensitize sensory neurons.  As a result of this sensitization, nociceptors exhibit lower thresholds 
and respond to innocuous stimuli (allodynia) and/or respond more robustly to noxious stimuli 
(Woolf and Ma, 2007).  Sensitizing molecules bind to their receptors on the membrane and 
activate multiple intracellular signal transduction pathways in peripheral terminal that include 
PKC (Hucho et al., 2005), PKA (Varga et al., 2006), PI3K, MAP kinases, ERK, p38, adenylyl 
cyclase and JNK (Doya et al., 2005; Jin and Gereau, 2006; Mizushima et al., 2007).  
Downstream of these signaling cascades are ion channels including TRP family channels (Zhang 
et al., 2005a; Zhang et al., 2005b; Bautista et al., 2006), voltage-gated sodium channels, G 
protein-coupled inwardly-rectifying potassium channels, and voltage-gated calcium channels 
(Kerr et al., 2001; Amaya et al., 2006).  In addition to driving peripheral sensitization, 
inflammation can activate retrograde signals in nociceptors that increase the transcription of 
neuropeptides (SP and CGRP), BDNF and sodium channels, and the translation/transcription of 
TRP channels (Neumann et al., 1996; Mannion et al., 1999; Ji et al., 2002).   
As seen in nerve injury models, inflammation has been linked with altered expression of 
trophic factors as well as ion channels and receptors in the DRGs.  Members of the GDNF family 
have been shown to produce significant behavioral hyperalgesia and nociceptor sensitization 
when injected acutely (Malin et al., 2006).  Following CFA injection, cutaneous Artemin and 
NGF were rapidly increased.  TRPV1 expression in the DRG was found to be increased in 
several models of acute inflammation, including formalin-induced (Usula et al., 2010), 
carrageenan-induced (Zacharova et al. 2009), and CFA-induced (Molliver et al., 2005; Malin et 
al., 2006) inflammation.  TRPV2 (Molliver et al., 2005; Shimosato et al., 2005) and several 
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ASICs (Voilley et al., 2001) were upregulated in the DRG in CFA-induced inflammation models 
as well.  A number of the Gq-coupled G-protein coupled nucleotide receptors discussed earlier 
were also shown to be increased in the DRG after inflammation, including P2Y1, P2Y2, P2Y4, 
and P2Y6 (Malin et al., 2008).  P2Y1 is of particular interest because it is commonly found on 
polymodal fibers (CPM) and colocalizes significantly with GFRα1, the GDNF receptor 
(Bradbury et al., 1998; Ruan and Burnstock, 2003; Malin and Molliver, 2010).  Moreover, P2Y1 
has been implicated in regulating CPM thermal sensitivity following inflammation (Malin et al., 
2008; Molliver et al., 2011; Jankowski et al., 2012).  The literature on nerve injury and 
inflammation both point to the potential significance of the signaling of target-derived growth 
factors and the expression of receptor proteins and ion channels in the neurons that respond to 
them. 
As discussed above, prior to this study, most work on primary afferent sensitization has 
been done using a variety of pathological conditions such as nerve injury or inflammation, in 
mice that overexpressed or were missing genes of interest, or following exogenous 
administration of pharmacological agents.  In the experiments described here, we focus on 
endogenous changes in molecular expression and sensory neuron function after contralateral 
nerve injury.  Preliminary findings revealed that many of the same neurotrophins and 
neurotrophic factors upregulated in the innervated hairy skin after saphenous nerve axotomy are 
similarly increased in the hairy skin innervated by the intact contralateral nerve.  In order to 
better understand how endogenous upregulation of target-derived neurotrophic factors might 
change the properties and molecular phenotype of intact afferents, we characterized the 
expression of several targets in the DRG that have been implicated in nociceptor sensitization, 
including, but not limited to, growth factor receptors, nucleotide receptors, Acid-sensing Ion 
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Channels (ASICs), and TRP channels.  We then recorded from these intact afferents at different 
timepoints to correlate any changes in their response properties with changes in expression of the 
genes we studied.  
 
1.4 CLINICAL IMPLICATIONS OF MIRROR IMAGE PAIN 
The results of these studies have other implications beyond simply helping us to understand how 
the phenotype of intact afferents might be altered after ongoing exposure to increased 
neurotrophic factor levels.  Although neuropathic pain is perceived to arise from the tissues 
innervated by damaged or inflamed nerves, pathological pain can also arise from sites 
contralateral to (the mirror image of) the site of pathology (Maleki et al., 2000; Watkins and 
Maier, 2002).  Indeed, the former study showed that nearly 15% of a cohort of patients with 
Complex Regional Pain Syndrome (CRPS) Type 1 developed pain symptoms in anatomical 
locations mirror opposite to where pain was first reported.  Mirror image pain is known to occur 
in a number of other persistent pain conditions, including CRPS Type 2 (also referred to as 
causalgia) (Shir and Seltzer, 1991), atypical facial pain (Woda and Pionchon, 2000), idiopathic 
facial arthromyalgia (Woda and Pionchon, 2000), and stomatodynia (Woda and Pionchon, 2000).  
It is typically characterized by mechanical allodynia (Moriwaki and Yuge, 1999; Baron, 2000).  
That is, mirror-image pain is perceived in response to light touch/pressure stimuli (Slart et al., 
1997).   
How mirror-image pain develops is poorly understood.  Although neuropathic pain from 
the area of nerve trauma can be accounted for, in part, by ectopic action potentials and 
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hyperexcitability (Woolf and Salter, 2000), no abnormal activity has previously been reported in 
the healthy contralateral nerve.  Hence, abnormal contralateral peripheral nerve responsivity not 
believed to account for mirror image pain.  A recent study showed that descending facilitation 
from the rostral ventral medulla (RVM) was essential for the development and maintenance of 
bilateral hypersensitivity following a unilateral intramuscular injection of acidic saline.  It has 
also been proposed that mirror image pain may arise from altered spinal processing of incoming 
sensory information (Koltzenburg et al., 1999; Watkins and Maier, 2002). Various neurocircuits 
have been proposed for how altered contralateral neural processing of pain may occur 
(Koltzenburg et al., 1999; Ossipov et al., 2000), but whether such neurocircuits adequately 
account for mirror-image allodynia is unknown.  Recent reports have suggested that increased 
DRG expression of TNFα and GFAP-positive satellite cells as well as an increase in GFAP-
positive astrocytes in the dorsal horn (Hatashita et al., 2008) may have a role in the emergence of 
mirror image pain in neuropathic pain models, but we know very little else about the 
neurochemical bases of this pain phenomenon.  In addition to understanding the potential impact 
of increased cutaneous neurotrophic factor expression on intact sensory neurons, one aim of the 
studies described here was to determine if there was significant primary afferent plasticity in the 
uninjured contralateral nerve after a unilateral injury.  The model we use here might shed some 
light on the potential role of increased target-derived neurotrophic factor levels on primary 
afferent sensitization in the development of mirror image pain.  Here we focus our attention on 
the potential molecular effectors of this primary afferent sensitization, specifically the 
neurotrophins and neurotrophic factors, as well as their receptors and associated ion channels in 
the DRG. 
 10 
1.5 TROPHIC FACTORS, RECEPTOR PROTEINS, AND ION CHANNELS 
 
1.5.1 Neurotrophins 
Neurotrophins regulate survival, development, function, and plasticity of the vertebrate 
peripheral nervous system (Korsching, 1993; Lewin and Barde, 1996; McAllister et al., 1999; 
Sofroniew et al., 2001).  There are four known neurotrophins in mammals: nerve growth factor 
(NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4 
(NT-4) (Levi-Montalcini and Hamburger, 1951; Cohen et al., 1954; Barde et al., 1982; Phillips et 
al., 1990; Ibanez et al., 1993).  Neurotrophins are synthesized and secreted by the targets of 
sympathetic and sensory neurons (Hallbook, 1999).  One class of neurotrophin receptors is 
comprised of three members of the tropomyosin-related kinase (trk) receptor tyrosine kinase 
family: trkA, trkB and trkC.  NGF binds trkA, BDNF and NT-4 bind trkB, NT-3 activates trkC 
and, to a lesser extent, trkA and trkB.  P75 neurotrophin receptor (p75NTR) is a receptor that 
binds to all neurotrophins with a similar affinity (Rodriguez-Tebar et al., 1991).  P75NTR 
enhances the response of trk to neurotrophins as well as increases the specificity of the Trk 
receptors for particular ligands. Both trkA and p75NTR receptors have nanomolar affinities for 
NGF and evidence from a variety of systems suggested they cooperate in tranducting NGF 
signaling (Bibel et al., 1999; Huang and Reichardt, 2003). The expression pattern of these two 
receptors overlaps extensively in sensory neurons (Karchewski et al., 1999; Rifkin et al., 2000), 
for example, in rat dorsal root ganglion (DRG) neurons, p75NTR is expressed in almost all 
neurons that express trkA (Wright and Snider, 1995).  In vitro, neurons coexpressing trkA and 
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p75NTR respond to lower concentrations of NGF than cells expressing trkA alone (Barker and 
Shooter, 1994; Hantzopoulos et al., 1994).  Coexpression of both receptors increases 25-fold of 
the association rate of NGF with trkA (Mahadeo et al., 1994). p75NTR enhances Trk response to 
preferred ligands (e.g., NGF for trkA, BDNF for trkB) while attenuating responses to 
nonpreferred ligands (e.g., NT3 for trkA). For example, trkB is readily activated by BDNF, NT3 
and NT4 in the absence of p75NTR. However, when p75NTR is coexpressed, only BDNF-
induced phosphorylatin of trkB remained unchanged, that induced by NT3 and NT4 was clearly 
reduced (Bibel et al., 1999). Other studies have shown that function-perturbing antibodies to 
p75NTR potentiated the NT-3 responses to trkA, suggesting that p75NTR suppresses the ability 
of trkA to respond to NT-3 (Clary and Reichardt, 1994).  
Neutrophins have been shown to directly bind to and dimerize trk receptors, which results 
in phosphorylation of tyrosine residues in the cytoplasmic domains of these receptors.  
Phosphorylation of these residues can activate intracellular cascades, which include 
Ras/extracellular signal-regulated kinase (ERK), phosphatidylinositol-3-kinase (PI-3)/Akt kinase 
pathway and phospholipase C-1 (PLC-1) (Huang and Reichardt, 2001).  During development, 
peripheral targets produce a limited amount of neurotrophins that act as survival factors and are 
thought to match the number of surviving neurons (half of all sensory and sympathetic neurons 
die during ontogeny), as well as the size and innervation density of target territories (Huang and 
Reichardt, 2001).  In addition to their role in sensory neuron development, neurotrophins are 
involved in neuronal regeneration and sensitization, making them ideal targets for investigation 
in these studies. 
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1.5.2 Glial Cell-line Derived Neurotrophic Factor (GDNF) Family Members 
The GDNF family ligands (GFLs) consist of GDNF, neurturin, artemin, and persephin. Each of 
the GFLs binds a preferred GDNF-family receptor-α (GFRα) that is coupled to the plasma 
membrane via a glycosyl phosphatidylinositol (GPI) anchor (Airaksinen and Saarma, 2002).  
GDNF preferentially binds GFRα1, neurturin preferentially binds GFRα2, artemin preferentially 
binds GFRα3, and persephin preferentially binds GFRα4. Persephin does not act as a 
neurotrophic factor in the PNS (Milbrandt et al., 1998) and will not be discussed further.  While 
GDNF and neurturin can also bind GFRα2 and GFRα1 (Jing et al., 1997), respectively, only 
artemin can activate GFRα3 (Baloh et al., 1998b). Upon GFL binding, the GFL/GFRα complex 
binds to the extracellular domain of the receptor tyrosine kinase (Ret).  This binding triggers 
autophosphorylation of the intracellular tyrosine residues which initiate a host of downstream 
intracellular signaling cascades.  The phosphotyrosine residues can activate various signaling 
pathways including RAS/ERK, PI3K/AKT, p38MAPK and JNK (Takahashi, 2001), important 
for a variety of cell processes including survival, proliferation, and neurite outgrowth.  In 
addition, the GPI-linked proteins cluster into lipid rafts in the plasma membrane and this location 
is critical for Ret signaling (Tansey et al., 2000). 
1.5.2.1 GDNF 
 
GDNF was purified from a rat glial cell line and shown to support embryonic dopaminergic 
midbrain neurons in vitro (Lin et al., 1993), creating great excitement that it might be used to 
treat neurodegenerative diseases, like Parkinson’s Disease.  In the peripheral nervous system, 
GFRα1-positive sensory neurons bind the lectin IB4, are peptide poor, and some appear to be 
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mechanoreceptors (Silverman and Kruger, 1988; Molliver and Snider, 1997; Bennett et al., 1998; 
Albers et al., 2006).  Mice lacking GDNF have a 23% loss of DRG neurons at postnatal day 0, 
fail to develop kidneys, and have deficits in the enteric nervous system (Moore et al., 1996).  In 
addition, mice overexpressing GDNF in the skin have a 27% increase in Ret-positive, IB4-
binding DRG neurons (Zwick et al., 2002), and the mechanical sensitivity of IB4-positive 
afferents is increased (Lawson et al., 2008).  The increased mechanical sensitivity was attributed 
to significant increases in DRG expression of acid-sensing ion channels 2a (ASIC2a) and 2b 
(ASIC2b) as well as transient receptor potential (TRP) channel, subfamily A member 1 
(TRPA1), which are mechanically-sensitive channels (Mullol et al., 1997; Price et al., 2000; 
Albers et al., 2006). 
 
 
 
1.5.2.2 Artemin 
 
GFRα3, the specific GPI-linked receptor for artemin, was cloned based on the sequence 
homology to the other members of GFRα receptor family, GFRα1 and α2 (Jing et al., 1997).  
Artemin was cloned as a binding ligand to GFRα3 based on the homology to GDNF and NRTN 
(Baloh et al., 1998).  Artemin can support the survival of sensory and sympathetic neurons in 
vitro (Baloh et al., 1998) and controls the migration of sympathetic precursors in vivo (Nishino et 
al., 1999). In adult mice DRG, 20% of neurons express GFR3. The majority of GFR3-
positive cells also express Ret (82%), trkA (80%), CGRP (70%), TRPV1 (99%) and peripherin 
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(97%), a marker of small diameter neurons that give rise to unmyelinated fibers (Orozco et al., 
2001). Overexpression of artemin in skin caused a 20.5% increase in DRG neuron number and 
an increase in the mRNA level of GFR3, trkA, TRPV1, and TRPA1.  Artemin overexpression 
also increased the behavioral sensitivity to both heat and noxious cold (Elitt et al., 2006). 
However, the most striking finding from this immunocytochemical characterization was that 
virtually all (99%) of GFRα3-positive neurons also express the capsaicin receptor, TRPV1, 
suggesting that the artemin responsive population of neurons were of great importance for 
nociception.  More recently, we showed that enhanced Artemin-GFRα3 expression appears to be 
essential for TRPV1 upregulation in regenerated DRG neurons and for the recruitment of CH 
fibers seen after nerve axotomy (Jankowski et al., 2011). 
 
1.5.3 Nucleotide Receptors 
Previous studies have shown that increased concentrations of extracellular adenosine 
triphosphate (ATP) contribute to the activation of primary afferents and hyperalgesia (Burnstock, 
1999).  Injection of ATP into the skin elicited a foot withdrawal response in rats (Bland-Ward 
and Humphrey, 1997) and produced a burning pain sensation in human subjects (Hamilton et al., 
2000).  The activation of sensory fibers by nucleotides such as ATP, ADP, and UTP appears to 
occur via two families of receptors: ionotropic P2X cation receptors and metabotropic P2Y G-
protein coupled receptors (GPCRs).  The seven subtypes of P2X receptors have been well 
characterized (Chen et al., 1995; Lewis et al., 1995, Bradbury et al., 1998), and their potential 
role in nociception has been investigated (Cockayne et al., 2000; Souslova et al., 2000; Honore et 
al., 2002; Shimizu et al., 2005), but less is known about P2Y receptors.  Eight members of the 
 15 
P2Y family have been identified, and of these receptors, the Gq-coupled P2Y1, P2Y2, and the 
Gi/o-coupled P2Y12, P2Y13, and P2Y14 are highly expressed in rat DRGs (Ruan and Burnstock, 
2003; Kobayashi et al., 2006).  
 
1.5.3.1 P2Y1 
 
One particular nucleotide receptor that has been hypothesized to be involved in C-polymodal 
(CPM) neuron heat sensitivity is P2Y1, a Gq-coupled GPCR.  Several studies have reported that 
P2Y1 is expressed in the subpopulation of small-diameter nociceptive sensory afferents that 
contain P2X3, bind to the IB4, lack TRPV1, and respond to adenosine diphosphate (ADP) 
(Burnstock, 1999; Volonte et al., 2006; Burnstock, 2007; Cockayne et al., 2000; Malin and 
Molliver, 2010; Malin et al., 2008; Borvendeg et al., 2003; Kress et al., 1992; Koltzenburg et al., 
1997).  In mice lacking the P2Y1 receptor, CPM neurons specifically were found to have 
significantly elevated thresholds to heat stimuli and lower thresholds to cold stimuli compared to 
wild-type mice (Molliver et al., 2010).  In a model of peripheral inflammation, paw withdrawal 
thresholds to radiant heat stimuli were reduced in P2Y1 knockout mice compared to WT mice 
(Malin et al., 2008).  Our laboratory has also recently shown that this population of cutaneous 
CPM fibers undergoes a similar decrease in heat thresholds following peripheral nerve injury and 
regeneration and that this decrease was correlated with changes in the expression of the two 
purinergic receptors, P2X3 and P2Y1 (Jankowski et al., 2009).  Injection of the P2Y1 agonist 
ADP into the hindpaw produced heat hyperalgesia in wildtype but not in P2Y1 knockout mice 
(Malin et al., 2010).  While these studies have suggested multiple functions for the P2Y1 
receptor in sensory perception, it has not been determined which neuronal cell types are 
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responsible for transducing P2Y1-mediated signals from the periphery.  Furthermore, the impact 
of P2Y1 signaling on the transduction of nociceptive stimuli has not been resolved.  In the 
present studies, we aimed to determine whether increased DRG expression of P2Y1 was 
correlated with functional changes in intact fibers. 
 
1.5.4 TRP channels 
Transient Receptor Potential (TRP) channels have also been targets for study in our and other 
labs, as their expression has been implicated in altering the functional properties of nociceptive 
neurons.  For many years, neurons that responded to noxious thermal, chemical or mechanical 
stimuli (nociceptors) were identified in part by their sensitivity to the “hot” or “spicy” ingredient 
in chili peppers, capsaicin.  Application of capsaicin to the skin leads to a psychophysical 
sensation of burning pain (LaMotte et al., 1991).  This sensation results from excitation of 
nociceptive neuron terminals and their local release of inflammatory mediators (CGRP and 
Substance P).  High doses of capsaicin in the neonatal period can ablate nociceptive neurons 
(Jancso et al., 1977), and repeated applications of capsaicin in the adult produce desensitization 
of nociceptors (Jancso et al., 1967; Jancso, 1992). This desensitization is the basis for over the 
counter capsaicin creams used to treat a variety of pain disorders (back pain, diabetic neuropathy, 
rheumatoid arthritis, etc.).  
The molecular transducer in nociceptors that produces these effects upon capsaicin 
application was unknown until Caterina et al. cloned the capsaicin receptor (Caterina et al., 
1997). They used a functional screening strategy by isolating candidate cDNA clones from DRG 
mRNA, injecting them into HEK293 cells and then assaying for capsaicin sensitivity using Fura-
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2 calcium imaging.  The newly cloned cDNA was initially named vanilloid receptor subtype 1 
(VR1), based on its responsiveness to members of the vanilloid family, capsaicin and 
resiniferatoxin.  TRPV1 contains six transmembrane domains with a short hydrophobic stretch 
between transmembrane regions 5 and 6 as well as three ankyrin repeat domains on the amino 
terminus.  It is also a distant relative of Drosophila transient receptor potential (TRP) ion 
channels, which mediate depolarization of photoreceptors in the fly (Montell and Rubin, 1989). 
Initial characterization showed that in addition to capsaicin, TRPV1 also responds to noxious 
heat (<42°) and acid (protons). A variety of related channels have since been cloned and are 
hypothesized to play important roles in thermosensation (Jordt et al., 2003; Dhaka et al., 2006). 
TRPV2 has been identified as an additional noxious heat channel, responding to temperatures 
>52°C in heterologous systems, whereas TRPV3 and TRPV4 respond to warmer temperatures 
(in the range of 27-39°C). In addition, two TRP channels that detect cold stimuli have also been 
identified. TRPM8 responds to innocuous cool temperatures (~8-28°C) and menthol whereas 
TRPA1 is activated by noxious cold temperatures <17°C as well as mustard oil, cinnamon oil, 
and bradykinin. Thus, at least in heterologous systems TRPV1, TRPV2 and TRPA1 respond to 
noxious temperatures and/or chemicals, whereas TRPV3, TRPV4 and TRPM8 can respond to 
non-noxious thermal stimuli. 
1.5.4.1 TRPV1 
 
TRPV1 is a nonselective cation channel gated by noxious heat (>43°C), protons, and vanilloid 
compounds (e.g. capsaicin, resiniferatoxin) (Caterina and Julius, 2001). TRPV1 is localized to a 
subset of small diameter nociceptors in trigeminal and dorsal root ganglia (Caterina et al., 1997). 
In mouse, TRPV1 is mainly expressed in IB4-negative, peptidergic neurons (Zwick et al., 2002).  
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Behavioral testing revealed that TRPV1 knockout mice have normal mechanical thresholds and 
relatively normal thermal thresholds (Caterina et al., 2000; Davis et al., 2000).  In contrast, in 
cultured DRG neurons from TRPV1-/- animals, the electrophysiological response to noxious 
heat is absent (Caterina et al., 2000; Davis et al., 2000).  However, in an ex vivo physiological 
preparation where the skin, DRG, and spinal cord are maintained intact in artificial CSF, the 
response of sensory neurons to noxious heat in TRPV1-/- mice does not differ from wildtype 
mice (Woodbury et al., 2004).  Therefore, in contrast to initial reports, TRPV1 does not appear to 
be necessary for the detection of noxious heat in naive animals.  
However, there is considerable evidence that TRPV1 is required for inflammation-
induced heat hyperalgesia.  WT mice injected with carrageenan or CFA (Complete Freund’s 
Adjuvant) become inflamed and develop robust thermal and mechanical hyperalgesia, whereas 
TRPV1 knockout mice do not experience thermal hyperalgesia following induction of 
inflammation (Caterina et al., 2000; Davis et al., 2000). Various laboratories have shown that 
inflammation or injury increases TRPV1 mRNA or protein (Tohda et al., 2001; Ji et al., 2002; 
Amaya et al., 2003; Molliver et al., 2005). In addition to increased synthesis of TRPV1, specific 
inflammatory mediators can sensitize TRPV1.  For example pro-algesic substances released 
during inflammation such as ATP (Moriyama et al., 2003) and bradykinin (Chuang et al., 2001; 
Sugiura et al., 2002) have been shown to sensitize TRPV1 and this sensitization is absent in 
TRPV1-/- knockouts. In addition, neurotrophic factors such as NGF are increased following 
inflammation (Donnerer et al., 1992) and can sensitize nociceptors by modulating TRPV1 
(Chuang et al., 2001; Galoyan et al., 2003).  Taken together, these studies indicate that TRPV1 is 
part of a common signaling pathway used by different modulators to produce hypersensitivity. 
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1.5.4.2 TRPA1 
 
Using genomic based approaches, TRPA1 (previously known as ANKTM1) was cloned and 
characterized as a noxious cold-activated ion channel (Story et al., 2003). TRPA1 is activated at 
colder temperatures than TRPM8; in heterologous expression systems, TRPA1 is activated in a 
broader range of activation temperatures (12-27ºC) with an average activation threshold of 17ºC 
(Story et al., 2003). TRPA1 is expressed in non-myelinated C- or lightly-myelinated A-fibers 
lacking coexpression with neurofilament 150. TRPA1 is co-expressed with CGRP, SP and 
TRPV1. TRPA1 is not, however, expressed with TRPM8 (Story et al., 2003). In addition to 
noxious cold, TRPA1 can be activated by the pungent natural compounds present in cinnamon 
oil, wintergreen oil, clove oil, mustard oil and ginger (Bandell et al., 2004).  
In 2006, two independent groups generated and characterized TRPA1 KO mice (Bautista 
et al., 2006; Kwan et al., 2006).  Kwan et al. (2006) showed a substantially reduced number of 
mustard oil-responsive neurons using calcium imaging and reduced behavioral sensitivity to oral 
or injected mustard oil, whereas Bautista et al. (2006) showed the complete absence of mustard 
oil response behaviorally or in dissociated neurons. These groups also had conflicting results 
regarding the behavioral responses to noxious cold. Bautista et al. (2006) found no difference in 
paw lifting latency on a cold plate (0ºC) and no difference in licking and flinching responses to 
evaporative cooling by application of acetone to the hindpaw. However, Kwan et al. (2006) 
found decreased behavioral responses to cold plate (0ºC) and acetone in TRPA1 KO mice. For 
both tests, the differences between WT and KO mice were larger for females than for males. 
Thus, the method of measuring the behavioral responses and the gender of mice used may have 
contributed to the conflicting results from these two laboratories.  In addition to its function in 
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cold nociception in sensory neurons, TRPA1 also contributes to cold hyperalgesia after 
inflammation and nerve injury.  Following CFA injection in rats, the percent of DRG neurons 
expressing TRPA1 mRNA increased from 32% to 44% and 42% at 1 and 3 days post-CFA, 
respectively. By day 7 post-CFA, these numbers returned to normal (Obata et al., 2005).  This 
upregulation can be induced by injection of NGF but not GDNF. Similar increases in TRPA1 
mRNA were also seen after L5 spinal nerve ligation (SNL) (Obata et al., 2005; Katsura et al., 
2006). Injection of an anti-NGF antibody, a p38 MAPK inhibitor or TRPA1 antisense 
oligodeoxynucleotide decreased the induction of TRPA1 and prevented inflammation- and nerve 
injury-induced cold hyperalgesia. These results provide evidence that NGF-induced TRPA1 
increase in sensory neurons via p38 activation is necessary for cold hyperalgesia following 
inflammation or injury.  
Taken together, these studies suggest that TRPA1 contributes to the transduction of 
mechanical, cold and chemical stimuli in sensory neurons. Moreover, since many afferents that 
express TRPA1 also express TRPV1 (Story et al., 2003), it is possible that interaction between 
these TRP channels plays a central role in the sensitization of primary afferents. 
 
1.5.5 Acid-sensing Ion Channels (ASICs) in Primary Afferents 
ASICs (acid-sensing ion channel), initially called MDEG (mammalian degenerin), BNC1 (brain 
Na+ channel 1), have been cloned in the late 90’s and thereafter identified as proton-gated 
channels (Waldmann et al., 1996; Garcia-Anoveros et al., 1997; Waldmann et al., 1997a). In 
rodents, at least six ASIC subunits (ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3, and ASIC4) 
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encoded by four different genes (ACCN1-4) have been described (Garcia-Anoveros et al., 1997; 
Waldmann et al., 1997a).  
ASICs are voltage-independent, proton-gated cation channels that are permeable to Na+ 
ions (Waldmann et al., 1997a).  In rodents, ASICs are widely present in the nervous system, 
central neurons express the ASIC1a and ASIC2 subunits (Price et al., 1996; Waldmann et al., 
1996; Garcia-Anoveros et al., 1997; Lingueglia, 2007). Whereas almost all ASIC isoforms are 
present in primary sensory neurons of the trigeminal, vagal and dorsal root ganglia. ASIC1, 
ASIC2, ASIC3 are significantly expressed in the small and medium-sized nociceptive sensory 
neurons that are able to detect noxious thermal, chemical and high-threshold mechanical stimuli. 
ASIC2 and ASIC3 are also expressed in large-diameter neurons that are low-threshold 
mechanoreceptors (Waldmann et al., 1997b; Waldmann et al., 1997a; Liu and Simon, 2000; 
Bassler et al., 2001; Garcia-Anoveros et al., 2001; Voilley et al., 2001; Alvarez de la Rosa et al., 
2002; Page et al., 2005; Fukuda et al., 2006).  ASICs are involved in cutaneous acid-induced 
pain elicited by moderated pH (up to pH 6.0).  For example, acid-induced cutaneous pain in 
healthy human volunteers can be blocked by amiloride, a non-selective ASIC channel blocker 
(Ugawa et al., 2002; Jones et al., 2004). The specific ASIC channel blocker A-317567 inhibits 
post-operative pain and inflammatory thermal hyperalgesia in rats (Dube et al., 2005).  Also in 
rats, local peripheral application of non-selective ASIC blockers amiloride and benzamil reduces 
cutaneous inflammatory pain (Rocha-Gonzalez et al., 2009).  
Several members of ASIC family have been proposed to participate in mechanosensation. 
ASIC2a and ASIC3 are expressed in mechanoreceptors, including specialized cutaneous 
mechanosensory structures like Merkel nerve endings, Meissner corpuscles, and palisades of 
lanceolate nerve endings surrounding the hair shaft (Price et al., 2000; Garcia-Anoveros et al., 
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2001; Price et al., 2001; Bounoutas and Chalfie, 2007). In ASIC2 knockout mice, the sensitivity 
of low-threshold rapidly adapting mechanoreceptors is markedly reduced (Price et al., 2000). 
ASIC3 knockout mice showed decreased sensitivity to noxious pinch (Price et al., 2001).  Mice 
overexpressing cutaneous GDNF had both increased mechanical sensitivity of cutaneous C-fiber 
nociceptors and DRG expression of ASIC2a and ASIC2b, while those overexpressing NT-3 had 
increased mechanical sensitivity in myelinated afferents in correlation with increased expression 
of ASIC1 and ASIC3 (Lawson et al., 2008). 
 
 
1.6 GOALS OF THE DISSERTATION 
Although significant work has been done to study the molecular mechanisms of the functional 
changes in sensory neurons after injury and regeneration, less is known about the behavior of 
intact fibers in response to endogenous changes in expression of target-derived neurotrophic 
factors.  Our initial finding that the hairy skin innervated by the intact saphenous nerve 
contralateral to a saphenous nerve injury had increased levels of several neurotrophins and 
neurotrophic factors motivated us to characterize those afferents to determine if they might 
exhibit any sensitization.  It has been shown that cutaneous injection of GDNF and Artemin 
induced behavioral sensitization to heat in experimental animals and sensitized nociceptors in 
vitro (Malin et al., 2006), and in light of the evidence for behavioral hypersensitivity 
contralateral to a unilateral injury in animal models (e.g. Chacur et al., 2001; Sluka et al., 2001; 
Milligan et al., 2003; Radhakrishnan et al., 2003; Arguis et al., 2008) and in human subjects and 
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patients (e.g. Shir and Seltzer, 1991; Maleki et al., 2000; Oaklander and Brown, 2004), we 
hypothesized that the increased levels of neurotrophic factors might sensitize intact afferents.  
We first performed a detailed analysis of the time course and anatomical specificity of changes 
in cutaneous expression.  Then, having characterized those molecular changes, we performed 
electrophysiological recordings using an ex vivo skin-saphenous nerve-DRG-spinal cord 
preparation to identify and characterize functional changes in the contralateral cutaneous sensory 
neurons that might correlate with mRNA changes.  Preliminary recording experiments suggested 
that at 4-5 weeks following contralateral nerve injury, C-polymodal fibers had reduced heat 
thresholds, and there was an increase in overall prevalence of C-heat fibers not seen at 2 weeks 
following contralateral injury.   
As discussed earlier, constitutive overexpression of neurotrophic factors can alter the 
sensitivity of nociceptors, and this effect may be mediated by changes in ion channel and 
receptor expression in the DRG (Stucky et al., 1999; Albers et al., 2006; Elitt et al., 2006; 
McIlwrath et al., 2007; Lawson et al., 2008).  This led us to hypothesize, therefore, that the 
functional changes observed in intact afferents might be correlated with changes in DRG 
expression.  In section 3.1, we discuss the mRNA expression changes in the L2,3 DRGs 
following contralateral nerve injury, including upregulation of many channels and receptors 
discussed already, such as the GDNF receptor GFRα1, nucleotide receptors P2Y1, P2Y2, and 
P2X3, and TRPV1.  The finding that the functional changes in intact afferents were evident at 4-
5 weeks but not at 2 weeks following contralateral injury suggested that a molecular change 
occurring between those two timepoints might be driving this change.  This focused our attention 
on P2Y1 and TRPV1, both of which were significantly upregulated in the DRGs at 28d but not at 
earlier timepoints.  Using an in vivo siRNA-mediated knockdown strategy, we were able to 
 24 
interrogate the roles of transient P2Y1 (Section 3.2) and TRPV1 (Section 3.3) upregulation in the 
change in response properties and molecular phenotype that was observed following 
contralateral saphenous nerve axotomy.  Specifically, we were able to block the increased 
expression of the targeted genes, evaluate potential off-target effects from the siRNA injections, 
and then record from saphenous afferents in order to determine if and how knockdown affected 
the functional changes normally seen after contralateral injury. 
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2.0  METHODS 
2.1 ANIMALS 
 
Experiments were performed on age-matched adult (6-10 weeks old) male Swiss-Webster mice 
(Hilltop, Scottdale, PA, USA) housed in the Department of Laboratory Animal Resources at the 
University of Pittsburgh.  Mice were house in temperature-controlled and light-controlled (12 
hour light/dark cycle) room and fed standard rodent chow and water available ad libitum.  
Animals were cared for and used in accordance with the United States Public Health Service 
Policy on Humane Care and Use of Laboratory Animals as well as the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals. 
2.2 SAPHENOUS NERVE AXOTOMY 
Mice were anesthetized with inhaled isoflurane.  The skin of the left hindlimb was shaved, and 
under aseptic conditions, a longitudinal incision was made in the skin at midthigh level, directly 
above the saphenous nerve, and the exposed saphenous nerve was transected using fine 
iridectomy scissors.  The proximal and distal segments of the nerve were left adjacent to one 
another to allow for regeneration, and the wounds were closed using 7–0 silk suture.  Animals 
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recovered from the anesthesia in a 28°C heated recovery chamber and were then transferred to 
their cages.  Previously published data (Jankowski et al., 2009) from naïve, uninjured Swiss-
Webster mice was used as a control.  We chose to use naïve mice as controls, rather than sham-
operated mice, in part because several studies have shown that in injury models such as sciatic 
nerve axotomy (Weissner et al., 2006) and L5 spinal nerve transection (Shortland et al., 2006), 
sham surgery produced a significant increase in the number of Substance P (SP)-positive neurons 
(Weissner et al., 2006) and an increase in ATF3-staining in the ipsilateral L4/5 DRGs (Shortland 
et al., 2006).  The latter study also showed an increase in DRG expression of injury markers such 
as Galanin, Neuropeptide Y (NPY), and Nitric Oxide Synthase (NOS).  A possible interpretation 
of these findings is that the surgical procedure to expose the nerves may have caused minor 
damage to axons on the nerve.  Although we do not know if either of these models produced any 
pathology in the contralateral DRGs, given that the saphenous nerve has a superficial course near 
the site of axotomy, we elected not to use sham-operated mice as controls in order to avoid any 
incidental nerve damage from the sham surgery.   
2.3 TOTAL RNA ISOLATION AND RT-PCR 
Animals were anesthetized with an intramuscular injection of a mixture of ketamine (90 mg/kg) 
and xylazine (10 mg/kg).  For each condition, one group (n=4) of these mice was used for real-
time PCR analysis of changes in neurotrophic factors expression in the skin, and a separate group 
(n=4) of animals were used for analysis of receptor and ion channel expression in the L2-3 
DRGs, at 7, 14, 21, and 28 days following contralateral saphenous nerve transection.  In order to 
determine if there were more widespread changes in cutaneous gene expression throughout the 
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body, we isolated RNA not only from hairy skin innervated by the saphenous nerve but also 
from remote areas of skin, including the hairy skin of the thighs, back, and forelimbs.  Hairy skin 
from the right (contralateral) hindpaw, ipsilateral and contralateral thighs, back, and ipsilateral 
and contralateral forelimb was rapidly removed, and RNA was isolated using Trizol reagent 
(Invitrogen, Carlsbad, CA, USA).  Prior to DRG isolation, anesthetized animals were perfused 
transcardically with 0.9% sterile saline.  RNA from DRG samples was isolated using Qiagen 
RNeasy Mini-Kits (Qiagen, Valencia, CA, USA).  The concentration and purity of the RNA was 
determined by using the 260 nm absorbance recorded by a spectrophotometer (Biochrom WPA, 
Cambridge, UK).  1 µg of total RNA was DNAse treated and then reverse transcribed with 
Superscript II Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA), and the resulting cDNA 
samples were stored at -80oC until needed.  To determine the relative mRNA levels of the 
specific neurotrophic factors and receptors/ion channels of interest, cDNA were tested by real-
time PCR using SYBR Green PCR Core Reagents and ABI Prism 7000 software (Applied 
Biosystems, Foster City, CA, USA).  Forward and reverse primer sequences for NGF, Brain-
derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4/5 (NT-4/5), GDNF, 
neurturin, artemin, tyrosine receptor kinase B (trkB), trkC, p75, GFRα1, GFRα2, P2X3, P2Y1, 
and P2Y2 were obtained from Jankowski et al. (2009), and sequences for glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), trkA, GFRα3, TRPV1, TRPV2, TRPV3, TRPV4, TRPA1, 
ASIC1, ASIC2a, ASIC3 were obtained from Elitt et al. (2006).  Primer sequences are all listed in 
the Appendix.  All genes of interest were normalized to GAPDH internal control.  Change in 
mRNA levels was determined using the ∆∆Ct method, whereby the mean cycle time (Ct) of the 
gene of interest was subtracted from the mean GAPDH Ct value for the given sample for each of 
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the different conditions, and fold change was calculated as 2∆∆Ct and a 2-fold change = 100% 
change. 
2.4 DEVELOPMENT OF siRNAs 
In order to investigate the role of specific genes in the functional changes observed in intact 
afferents, we utilized an in vivo siRNA-mediated knockdown strategy.  Briefly, siRNA were 
designed to target the open reading frame of the gene of interest. Non-targeting controls were 
engineered and tested by Dharmacon (Lafayette, CO).  For each gene targeted (here, P2Y1 and 
TRPV1), 4 different siRNAs duplexes were developed and tested as described in Jankowski et al. 
(2006). Briefly, mouse neuroblastoma Neuro2A cells (ATCC clone number CCL-131, Manassas, 
VA, USA) were maintained in Eagle’s minimal essential medium (MEM) containing 10% fetal 
bovine serum (MEMS) and 1% penicillin/streptomycin in an incubator set at 37 °C at 5% CO2.  
For all experiments, cells were plated into 12-well plates at a concentration of 10,000 cells/well. 
C ells were grown in MEMS to 50% confluence (18–24 h) and were transfected with the siRNA 
of interest and TRANSIT-TKO transfection reagent in serum-free MEM to reach a final siRNA 
concentration of 10 nM.  24 h after siRNA transfection, the plates were harvested for RNA using 
the Qiagen RNeasy Mini Kit, and the siRNA duplex which produced the most significant mRNA 
knockdown of the target gene vs. control siRNA was selected for thiol modification.  SiRNA 
duplexes were modified with a 5’ thiol group on the sense strand and HPLC purified 
(Dharmacon, Lafayette, CO) to allow for conjugation with Penetratin-1, a 16 amino acid peptide 
corresponding to the third helix of the Antennapedia homeodomain protein which enters cells in 
a non-receptor-mediated manner (Derossi et al., 1994). Annealed siRNA duplexes were 
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resuspended in buffer provided by the manufacturer and treated with an equimolar mixture of 
Tris (2-carboxyethyl)phosphine at 20°C for 15 min. An equimolar ratio of Penetratin-1 (Q-
Biogene, Carlsbad, CA) was added, and the mixture was heated to 65°C for 15 min and then 
incubated at 37°C for 1 hr before being aliquotted and stored at -80°C. 
2.5 siRNA INJECTION PROTOCOL 
In all animals receiving siRNA injections, a small incision was made in the skin above the right 
saphenous nerve (mid-thigh level), and an approximately 1 mm segment of the saphenous nerve 
was freed from the surrounding muscle without damaging the nerve or nearby vasculature.  A 
chilled piece of parafilm was then placed under the freed segment of the nerve to provide 
stability.  Penetratin-linked siRNAs were heated to 60°C for 5 minutes prior to injection, and 
0.1–0.2 μL of 80 μM Penetratin-1 linked control, non-targeting (PenCON) or gene-targeting 
(PenY1 or PenV1) siRNAs were pressure injected directly into the saphenous nerve via a quartz 
electrode connected to a picospritzer.  Injections were done at 10 psi using 7-10 pulses of 100ms 
duration.  In order to identify an appropriate injection paradigm to block P2Y1 and TRPV1 
upregulation, respectively, we measured mRNA levels in the L2,3 DRGs at 28d after 
contralateral saphenous nerve axotomy using two injection protocols, using 6 SW mice in each 
group.  Both P2Y1 and TRPV1 were significantly upregulated at 28d, so we hypothesized that 
either a single injection of gene-targeting siRNA at 14d or a double injection done at 14d and 
21d post-injury might block their respective increase in expression.  For PenY1 experiments, the 
single injection at 14d did not block the contralateral injury-induced P2Y1 upregulation (44 ± 
18% increase vs. naïve controls), but the double injection protocol at 14d and 21d was effective 
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(-5 ± 16% change P2Y1 mRNA vs. controls) and was therefore used in all PenY1/PenCON 
experiments here.  In PenV1 mice, both the single injection (-10 ± 8% change vs. controls) and 
the double injection (-16 ± 9% change vs. controls) effectively blocked the increase in TRPV1 
mRNA expression.  In order to minimize potential injury to the intact saphenous nerve, we chose 
to use a single injection of siRNAs at 14d after contralateral injury for all PenV1/PenCON 
experiments.  It should be noted that control siRNA injections for each experimental condition 
were done at identical timepoints as the gene-targeting siRNA injections i.e. control siRNA 
injections in PenY1 experiments were performed at 14d and 21d after contralateral nerve injury, 
while control injection in PenV1 experiments was done at 14d after contralateral nerve injury. 
2.6 PROTEIN ISOLATION AND WESTERN BLOT 
Hairy skin of the hindpaw innervated by the saphenous nerve or L2-3 DRGs were isolated from 
naïve and injured mice, as described above, and samples were homogenized in a lysis buffer 
containing 10 mM Tris-HCl, 1% Sodium Dodecyl Sulfate (SDS), and protease inhibitors (1 
µg/mL pepstatin, 1 µg/mL leupeptin, 1 µg/mL aprotinin, 1 mM sodium orthovanadate, and 100 
µg/mL phenylmethylsulfonyl fluoride) and then centrifuged at 4°C for 5 min in order to isolate 
soluble protein.  Protein samples (20 µg) were boiled for 10 minutes in a denaturing buffer 
containing SDS and β-mercaptoethanol, separated on a 15% SDS-PAGE gel, and then 
transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, MA, USA) 
overnight.  Membranes were blocked and then incubated with primary antibodies overnight at 
4°C (Artemin (1:200) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), GDNF (1:200) (Santa 
Cruz), GAPDH (1:1000) (ProSci Inc., Poway, CA, USA), P2Y1 (1:800) (Alomone Labs, Israel).  
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Antibody binding was visualized via infrared fluorescent secondary antibodies (donkey anti-
goat, donkey anti-rabbit, or donkey anti-chicken, 1:10000 concentration) on a LI-COR Odyssey 
system (LI-COR, Inc., Lincoln, NE, USA).  Molecular weights of protein bands were estimated 
using a prestained standard (BioRad, Hercules, CA, USA). 
2.7 IMMUNOHISTOCHEMISTRY OF WHOLE DRGS AND NEUROBIOTIN-
STAINED CHARACTERIZED NEURONS 
IB4-binding and TRPV1-staining in the right L3 DRGs were measured in four mice each from 
three groups: uninjured mice; 2 weeks post-axotomy of the left saphenous nerve; 4 weeks post-
axotomy of the left saphenous nerve using the methods described previously (Christianson et al., 
2006).  Briefly, mice were anesthetized with a ketamine/xylazine mixture as described above and 
then perfused with ice-cold 0.9% saline.  The right L3 DRGs were rapidly removed, fixed in 4% 
paraformaldehyde (PFA) for 30 minutes, and then placed in 0.1 M phosphate buffer (PB) at 4°C 
overnight.  DRGs were embedded in 10% gelatin, fixed in 4% PFA, and then cryoprotected in 
20% sucrose.  The embedded ganglia were then sectioned into 60 µm slices and collected into 
PB.  Slices were blocked and then incubated in primary for TRPV1 (1:2000, Alomone Labs, 
Israel), while IB4-binding was assessed using Alexa Fluor 647-conjugate (1:100, Invitrogen).  
Tissues were then washed and incubated in Cy3-conjugated donkey anti-rabbit secondary 
antibody (1:200; Jackson ImmunoResearch Laboratories, West Grove, PA, USA).  For each 
ganglion, three non-consecutive sections were chosen randomly, and then 15-21 µm stacks with 
3 µm sections were imaged confocally using a 40X oil-immersion lens (Olympus, Center Valley, 
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PA, USA).  Non-overlapping top and bottom sections within each stack were identified, and the 
total number of cells binding IB4 and staining for TRPV1 was measured. 
2.8 PGP9.5 STAINING AND QUANTIFICATION OF INNERVATION DENSITY OF 
HAIRY SKIN INNERVATED BY SAPHENOUS NERVE 
In order to investigate potential changes in skin innervation density, sections of the right hairy 
hind paw skin innervated by the saphenous nerve were isolated from mice at 14 and 28 days after 
contralateral saphenous nerve axotomy as well as from uninjured controls.  These sections were 
processed immunohistochemically as described above and were then blocked and incubated in 
rabbit anti-PGP9.5 primary antibody (1:2000; Ultraclone, Isle of Wright, UK) overnight at room 
temperature. After incubation in primary antiserum, tissue was washed and incubated in Cy3-
conjugated goat anti-rabbit secondary antibody (1:200; Jackson). Samples were then analyzed 
using confocal microscopy as described above.  Nerve fiber density was then determined using 
Image J software as described in Anderson et al. (2010).  Three non-consecutive sections of skin 
were used to calculate nerve fiber density.  Within each image, the area to be quantified was 
outlined with the freehand selections tool to create a region of interest (ROI) including the 
epidermis and upper dermis.  In order to exclude background fluorescence of collagen and other 
non-specific staining, the Image>Adjust>Threshold function was used. The same threshold was 
then applied to all images from the same region for all sections from each slide.  The 
Analyze>Measure function was then used to measure the aggregate of the selected features.  This 
included the total area of the ROI and the area within the ROI that was immunostained.  This 
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was then expressed as percent area within ROI (density of staining as % of area). For each 
condition, 6 images each from 3 mice were analyzed and the results averaged.   
2.9 EX VIVO PREPARATION AND ELECTROPHYSIOLOGICAL RECORDING 
We used an ex vivo somatosensory preparation in which the hairy skin, peripheral nerve, 
DRGs, and spinal cord were dissected intact (e.g. McIlwrath et al., 2007; Lawson et al 2008) 
(Figure 1).  Mice were anesthetized with a ketamine/xylazine mixture as described above.  Mice 
were then perfused transcardially with ice-cold oxygenated artificial CSF (aCSF) (1.9 mM KCl, 
1.2 mM KH2PO4, 1.3 mM MgSO4, 2.4 mM CaCl2, 26.0 mM NaHCO3, and 10.0 mM D-glucose) 
containing 253.9 mM sucrose and no sodium ions.  The right hindlimb and lumbar spinal cord 
were surgically removed and placed in a dish containing the circulating aCSF.  The hairy 
hindpaw skin, saphenous nerve, L1-4 DRGs, and lumbar spinal cord were isolated intact and 
then transferred to a recording chamber containing oxygenated aCSF with the sodium ions 
replaced (127.0 mM NaCl).  The skin was pinned onto a wire mesh grid with the epidermal 
surface of the skin up and the dermal surface of the skin perfused by the circulating aCSF.  The 
bath temperature was gradually raised to 31°C.  A suction electrode was placed on the saphenous 
nerve to stimulate DRG cells electrically with a square-wave pulse.  A quartz recording 
microelectrode containing 5% Neurobiotin (NB) (Vector Labs, Burlingame, CA, USA) in 1 M 
potassium acetate was impaled in the DRG (either L2 or L3) for single-cell recording of action 
potentials.  If a cell responded to the electrical stimulus, the skin was tested with a brush or von 
Frey filament to determine a mechanical receptive field, and if the cell had no mechanical field, 
the skin was tested for a response to cold (31°C) and hot (54°C) 0.9% sterile saline.  In the event 
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there was a receptive field, a digitally-controlled mechanical stimulator (Aurora Scientific, 
Aurora, ON, Canada) and/or Peltier thermode (Yale University, New Haven, CT, USA) were 
used for characterization of the cell’s response properties.  The mechanical stimuli were applied 
for 5s at 1, 5, 10, 25, 50, and 100 mN, with 25s of break between successive stimuli to allow for 
recovery.  A-fibers were also tested with a 100mN stimulus at 5Hz and 50Hz in order to 
characterize the cell’s ability to adapt.   The Peltier thermode applied was 3 mm2 in surface area.  
Figure 1. Diagram of ex vivo preparation. (Left panel) The hairy skin of the right hindpaw, 
intact, saphenous nerve, dorsal root ganglia, and spinal cord are dissected in continuity.  DRG 
neurons are impaled with a quartz electrode, and cells of interest are identified with an 
electrical search stimulus.  Neurons with cutaneous receptive fields have their mechanical and 
thermal responses characterized (stimulus paradigm on right panel).  Figure adapted from 
Lawson et al. (2008). 
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Data were acquired using an AxoClamp 2B (Molecular Devices, Sunnyvale, CA, USA) and 
Spike2 software (Cambridge Electronic Design Limited, UK), and offline analysis, including 
determination of conduction velocity, spike width, mechanical and thermal thresholds, and 
mechanical and thermal firing rates, was performed using Spike2.  Cells of interest were 
iontophoretically injected with Neurobiotin.  After completion of a recording session, ganglia 
with Neurobiotin-stained cells were fixed in 4% PFA for 30 minutes and then incubated in 0.1M 
PB.  They were then embedded in gelatin, sectioned, and incubated with fluorescently-tagged 
Avidin-FITC (Vector Laboratories) to identify Neurobiotin-stained cells and processed for IB4-
binding and TRPV1-staining as described above. 
2.10 ANALYSIS OF PRIMARY AFFERENT RESPONSE PROPERTIES 
Characterized fibers were first identified as A-fibers or C-fibers based on their respective 
conduction velocities (CV), calculated from the latency of the search stimulus and the distance 
from the stimulating electrode to the ganglion.  Those afferents with a CV of less than 1.2 m/s 
were characterized as C-fibers (Kress et al., 1992; Koltzenburg et al., 1997); those with a CV 
between 1.2 m/s and 10 m/s were classified as A-delta (Aδ) –fibers, and those with CVs 
exceeding 10 m/s were classified as Aβ-fibers.  Based on their mechanical response properties 
and spike shape, A-fibers were classified further as low-threshold mechanoreceptors or 
nociceptors (Koerber et al., 1988).  Mechanical thresholds were the primary determinant in this 
classification, but any fibers with low mechanical thresholds and an inflected spike with a broad 
action potential would be considered myelinated nociceptors.  The low-threshold 
mechanoreceptors consisted of Aβ rapidly adapting fibers, slowly-adapting (SA1) fibers, and Aδ 
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(D hair) hair follicle afferents, while myelinated nociceptors were classified based on their 
thermal sensitivities as A-mechano (AM) or A-polymodal (APM, both mechanical and thermal).  
C-fibers were classified by their response properties as follows: C-mechano (CM), responding 
only to mechanical stimuli; C-cold (CC), responding only to cooling/cold; C-mechanocold 
(CMC), responding to mechanical and cooling/cold stimuli; C-polymodal (CPM, including fibers 
responding to both mechanical and heat stimuli and those fibers responding to mechanical and 
both heat and cold stimuli); and C-heat (CH), responding only to heat stimuli.   
2.11 STATISTICAL ANALYSIS 
Mean heat and cold thresholds, RT-PCR data, and Western blot band intensities were analyzed 
using a one-way analysis of variance (ANOVA) with Tukey’s post hoc test to determine pairwise 
differences between experimental groups and uninjured mice, with a p value of 0.05 set as 
threshold for statistical significance.  Mean heat firing rates and DRG cell counts were analyzed 
using a two-way ANOVA with post hoc Bonferroni correction.  A nonparametric, Kruskal-
Wallis test with Dunn’s post hoc analysis was applied to mechanical thresholds.  Fisher’s exact 
test was used to determine changes in the proportion of recorded C-fiber types in each group 
relative to uninjured mice.  All numerical data are presented as mean ± standard error of the 
mean (S.E.M.). 
 37 
3.0  RESULTS 
3.1 CHANGES IN MOLECULAR EXPRESSION AND SENSORY NEURON 
FUNCTION AFTER CONTRALATERAL INJURY 
3.1.1 Unilateral saphenous nerve axotomy induces changes in expression in the 
contralateral skin and L2,3 DRGs 
We examined changes in expression of several neurotrophin (NGF) family members, GDNF 
ligands, and ion channels in the skin innervated by the right saphenous nerve, at 7, 14, 21, and 28 
days post-axotomy of the left saphenous nerve, collecting samples from four mice in each group.  
As early as seven days post-axotomy of the left saphenous nerve, we observed a statistically 
significant increase in artemin (123 ± 19% increase) mRNA expression in the right 
(contralateral) hairy hindpaw skin, and it remained at elevated levels through the 28d timepoint.  
This was similar to what was seen on the ipsilateral saphenous nerve skin, where Artemin 
mRNA was significantly increased from 7d-21d after axotomy (Table 2, Jankowski et al., 2009).  
GDNF (42 ± 9%) was elevated at 21d following axotomy but were not significantly different 
from uninjured mice at the other timepoints (Table 1), slightly different from the ipsilateral side, 
where it GDNF was increased as early as 7d post-axotomy (Table 2).  Neurturin (40 ± 15%) was 
elevated at 21d following axotomy but were not significantly different from uninjured mice at 
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the other timepoints (Table 1), similar to the injured side where it was not increased at any 
timepoint (Table 2).  NT-4/5 was the earliest neurotrophin with increased mRNA in the 
contralateral skin, evident from 7d (82 ± 21%) through 21d (39 ± 11%) after axotomy, similar to 
what was observed on the injured side (Table 2).  Surprisingly, by 14d, BDNF was elevated (39 
± 12%), and at 21d, expression of BDNF (50 ± 16%), NGF (67 ± 13%), and NT-3 (46 ± 18%) 
were significantly higher than uninjured controls, changes that were not observed on the injured 
side.  Among neurotrophin family members, only NGF was elevated at 28d (56 ± 17%).  TRPV3 
was upregulated (88 ± 18%) at 7d post-axotomy but returned to baseline levels from 14d-28d, 
whereas TRPV4 was elevated (120 ± 27%) at 7d and remained upregulated through day 28.  The 
changes in TRPV3 and TRPV4 expression strongly correlate with what is observed on the 
injured side (Table 2).   Generally, changes in the contralateral skin mirrored what was seen in 
the skin innervated by the axotomized saphenous nerve, but there were some differences, 
Table 1. Changes in trophic factor levels after contralateral saphenous nerve 
axotomy. mRNA levels in skin after saphenous nerve axotomy, at 7, 14, 21, and 28d.   
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specifically upregulation of BDNF, NT-3, and Neurturin in the contralateral skin that were not 
seen ipsilaterally as well as a smaller change in GDNF compared to the ipsilateral side.  We also 
analyzed changes in protein expression of Artemin and GDNF in the hairy hindpaw skin at 14 
days following contralateral saphenous nerve axotomy.  We found that both GDNF (786 ± 
192%) and Artemin (180 ± 95%) protein were significantly upregulated 14d after contralateral 
injury vs. naïve controls (Fig 2). 
 
 
 
 
Figure 2. Artemin and GDNF Western blots. Western blot analysis of neurotrophic factor 
expression in the hairy hindpaw skin of mice that were uninjured and had the contralateral 
saphenous nerve transected 14d prior.  Both GDNF (A) and artemin (B) were significantly 
upregulated (C) in the hairy hindpaw skin at 14 days after contralateral saphenous nerve 
axotomy.  Significance indicated as p<0.05 (*), One-way ANOVA with Tukey’s post hoc test 
vs. uninjured mice. 
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In order to determine whether these changes were occurring systemically (at multiple 
locations), or whether they were limited to symmetrical locations, we characterized the changes 
in cutaneous expression bilaterally at several symmetrical sites remote from the injury. These 
sites included the thighs, back, and forelimbs, and were also examined at the same timepoints (7, 
14, 21, and 28 days) following axotomy of the left saphenous nerve.  In the hairy skin of the back 
and bilateral forelimbs, there was no significant change in mRNA levels of any of the genes 
tested at any of the four timepoints (data not shown).  We did, however, detect a significant 
increase in expression of cutaneous artemin (61 ± 18% at 7d, 56 ± 20% at 14d, 47 ± 10% at 21d, 
and 77 ± 22% at 28d), GDNF(45 ± 17% at 14d and 66 ± 23% at 28d), and neurturin (40 ± 17%) 
in the ipsilateral thigh at various timepoints, and artemin was upregulated (42 ± 13%) in the 
contralateral thigh at 21 days after axotomy.  Thus, the change in neurotrophic factor expression 
Table 2. Ipsilateral changes in cutaneous trophic factor levels.  Expression of several 
neurotrophins, neurotrophic factors, and ion channels in the hairy hindpaw skin after 
saphenous nerve axotomy, at 7, 14, 21, and 28d.   
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was mostly limited to symmetrical locations in the hairy hindlimb skin including the skin 
innervated by the saphenous nerve and to a smaller degree in adjacent intact skin most 
predominantly on the side of the lesion. 
 42 
 
 
Table 3. Remote changes in cutaneous trophic factor levels.  Changes in expression of 
several trophic factors and ion channels in the skin of the thigh, back, and forelimb after 
unilateral saphenous nerve axotomy, at 7, 14, 21, and 28d. Significance (p<0.05, One-way 
ANOVA with Tukey’s post hoc test vs. uninjured mice) is indicated with the yellow boxes. 
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Next, we characterized changes in DRG expression of several neurotrophic factor 
receptors, as well as, a number of associated receptor/channel proteins (e.g. ASICs, TRP 
channels, and ionotropic P2X and metabotropic P2Y receptors) to determine if changes in 
neurotrophic factors seen in the dorsal hindlimb hairy skin were correlated with expression 
changes in the intact L2 and L3 ganglia.  The GDNF receptor GFRα1 was significantly 
increased at day 14 and remained elevated through day 28 (77 ± 24% at 14d, 59 ± 11% at 21d, 
Table 4. Changes in receptor and ion channel expression in contralateral DRGs.  
Expression of several neurotrophin and neurotrophic factor receptors, TRP channels, ASIC, 
and nucleotide receptors in the L2-3 DRGs, at 7, 14, 21, and 28d after contralateral saphenous 
nerve axotomy.  Significance (p<0.05, One-way ANOVA with Tukey’s post hoc test vs. 
uninjured mice) is indicated with the yellow boxes.  
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100 ± 13% at 28d), but we saw no changes in expression of GFRα2 or GFRα3 (Table 3).  
Expression of P2X3 was elevated throughout the 7d-28d period, first elevated at day 7 by 86 ± 
22%, and P2Y2 was increased at 14d (179 ± 26%) and was still elevated at 21d (188 ± 30%) and 
28d (49 ± 14%).  At 21d only, ASIC1 (44 ± 12%) and ASIC3 (47 ± 21%) were significantly 
upregulated.  By 28d, we also detect increased expression of TRPV1 (43 ± 15%) and P2Y1 (55 ± 
10%).  TRPV2 was upregulated at 7d (37 ± 17%) and 21d (50 ± 10%) after contralateral injury.  
We saw no changes in expression of any of the trk receptors, the p75 low-affinity neurotrophin 
receptor, ASIC2a, or TRPA1 at any of the four timepoints. 
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3.1.2 Functional characterization of cutaneous afferents contralateral to nerve injury  
In order to determine if there were any functional changes correlated with the increased 
expression seen in the skin and DRGs, we performed ex vivo recordings of primary afferents in 
the intact contralateral saphenous nerve.  We characterized a total of 54 cutaneous fibers (11 A-
fibers and 43 C-fibers) from 11 mice in the 2 week contralateral axotomy group and a total of 74 
fibers (10 A-fibers and 64 C-fibers) from 15 mice in the  4-5 week contralateral axotomy group.  
Table 5. Ipsilateral changes in receptor and ion channel expression.  Expression of 
several neurotrophin and neurotrophic factor receptors, TRP channels, Acid-sensing ion 
channels (ASIC), and nucleotide receptors in the L2-3 DRGs, at 7, 14, 21, and 28d after 
saphenous nerve axotomy.  
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We chose the 2 week and 4-5 week timepoints because a number of genes had increased 
expression at 21d and 28d that were not upregulated at 7d or 14d, so we hypothesized that the 
increased expression might be correlated with a functional change.  Additionally, there were 
several functional changes observed in the regenerating (ipsilateral) nerve at a similar time point 
(Jankowski et al., 2009).  Moreover, there was significantly increased expression of GFRα1, 
TRPV1, TRPV2, ASIC1, ASIC3, P2X3, P2Y1, and P2Y1 during the 3-4 week period, whereas 
only GFRα1, TRPV2, P2X3, and P2Y2 were elevated at 2 weeks, suggesting that there might be 
measurable differences between the two timepoints.  Only cells with mechanical and/or thermal 
cutaneous receptive fields were characterized.  The two experimental groups were compared to 
previously published data  (Jankowski et al., 2009) of fibers recorded from uninjured Swiss-
Webster controls using an identical protocol to the one outlined here.  We have outlined a 
description of the process by which the response properties of neurons with a cutaneous 
receptive field was characterized in Section 2.9. 
3.1.3 The response properties of myelinated nociceptors do not change in the 
contralateral nerve at 2 weeks or 4-5 weeks post-axotomy 
Among myelinated nociceptors, there was no change in the mechanical thresholds of Aβ-fibers 
(25.1 ± 5.4 mN at 2 weeks, 21.8 ± 4.7 mN at 4-5 weeks) vs. naïve controls (23.3 ± 3.7 mN) or 
Aδ-fibers (19.4 ± 6.5 mN at 2 weeks, 18.9 ± 5.0 mN at 4-5 weeks) vs. naïve controls (20.8 ± 3.0 
mN).  We also did not observe any significant change in the mean firing rates or conduction 
velocities of either group vs. those in naïve mice (data not shown).  There were not a sufficient 
number of fully characterized low-threshold mechanoreceptors identified in either group to 
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compare with naïves.  We did not identify any A-fibers with heat sensitivity and therefore could 
not assess any change vs. uninjured controls. 
 
3.1.4 C-polymodal fibers are sensitized to heat 4-5 weeks after contralateral injury 
At 2 weeks after contralateral nerve injury the heat thresholds of CPM fibers in the intact 
saphenous nerve were nearly identical to control values (42.6 ± 0.9 °C) (Figure 3A). However, 4-
5 weeks after contralateral injury, CPM-fibers in the intact nerve had a significantly reduced heat 
threshold (39.4 ± 0.9 °C) vs. uninjured controls (42.6 ± 0.5 °C), surprisingly consistent with 
changes in the regenerated nerve (39.8 ± 1.2°C) reported in Jankowski et al. (2009).  The 
reduced CPM heat threshold notably correlated with the significantly increase mRNA levels of 
GFRα1 and P2Y1 (Table 2), of which the latter has been shown to be important in normal heat 
sensation in the CPM population (e.g. Molliver et al., 2011). Mechanical thresholds of CPM 
fibers were not altered in the 2 week group (16.8 ± 3.4 mN, p=0.2) or 4-5 week group (17.4 ± 3.1 
mN, p=0.3) compared to uninjured mice (20.9 ± 2.2 mN), (Figure 3B).  There were also no 
significant differences in the mean firing rates of CPM-fibers to mechanical or thermal 
stimulation or of CH-fibers to thermal stimulation (data not shown).  
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Figure 3. CPM Mechanical and Thermal Thresholds. Mean heat thresholds in 
characterized CPM fibers (A) were lower at 4-5 weeks following contralateral injury 
than at 2 weeks or in naïve mice.  There was no difference in mean CPM mechanical 
thresholds (B) among the three groups.  Significance is indicated as p<0.05 (*), One-way 
ANOVA with Tukey’s post hoc test vs. uninjured mice. 
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3.1.5 There is increased prevalence of C-heat fibers and decreased prevalence of C-
mechano fibers 4-5 weeks after contralateral nerve injury 
The heat thresholds of CH neurons in both the 2 week (43.1 ± 3.6 °C) and 4-5 week (41.5 
± 2.9 °C) groups were not statistically different from naives (41.0 ± 1.6 °C).  In addition to 
characterizing the response properties of individual afferents, we also examined the distribution 
of C-fiber types in each experimental group to determine any change in relative fiber prevalence.  
Although the heat thresholds and mean firing rates of CH-neurons in both experimental groups 
were not different from CH-fibers in naïve controls, there was a substantial increase in the 
proportion of CH-fibers at 4-5 weeks (20% of all characterized C-fibers vs. 4% in uninjured 
mice), while the 2 week contralateral group (9%) was slightly increased but not significantly 
different from naïve controls (Figure 4).  Like the change in CPM heat threshold reduction, the 
increase in proportion of CH-fibers agreed with what was observed in regenerated saphenous 
nerves, in which 23% of cutaneous C-fibers were mechanically-insensitive CH fibers (Jankowski 
et al., 2009).  The increase in CH prevalence here corresponded with a dramatic reduction in the 
prevalence of CM-fibers at the 4-5 week timepoint (2%) vs. uninjured mice (18%) that was not 
seen at 2 weeks (16%).  Notably, this differed from regenerated nerves, in which there was a 
small but not significant decrease of CM prevalence to 8% following saphenous nerve axotomy 
(Jankowski et al., 2009).  Dividing C-fibers into a heat-responsive or non-heat-responsive group 
revealed that the overall prevalence of heat-responsive fibers was also significantly increased in 
the 4-5 week contralateral group vs. controls but not in the 2 week contralateral injury mice. 
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3.1.6 Immunostaining of functionally identified C-fibers 
In the 2 week group, we intracellularly stained a total of 11 functionally characterized C-
fibers from the ex vivo recording preparation with Neurobiotin (10 CPMs, 1 CH), and we stained 
17 C-fibers in the 4-5 weeks group (15 CPM, 2 CH).  Two examples of characterized stained 
cells are in Figure 5.  In each case, the tissue was processed to assess whether the given cell 
bound IB4 and/or stained positively for TRPV1.  In uninjured mice, nearly all CPM-fibers bind 
IB4 and never express TRPV1, and CH-fibers always express TRPV1 and do not bind IB4 
Figure 4. Recruitment of CH neurons.  All characterized C-fibers were classified by 
their response properties as C-mechano (CM), C-cold (CC), C-mechanocold (CMC), C-
polymodal (CPM), and C-heat (CH).  There was a statistically significant increase in the 
proportion of recorded CH-fibers in the 4-5 week group vs. uninjured mice that was not 
seen at 2 weeks.  This is similar to what is observed in regenerated fibers.  Significance 
is indicated as p<0.05 (*), Fisher’s exact test vs. uninjured mice. 
 
 51 
(Table 6).  At 2 weeks following contralateral saphenous nerve axotomy, all stained CPM fibers 
(10/10) bound IB4 and did not express TRPV1, while the only stained CH neuron did not bind 
IB4 and stained positively for TRPV1.  By 4-5 weeks however, a number of CPM fibers stained 
positively for TRPV1 (3/15, or 20%), consistent with what is seen in the ipsilateral L2-3 DRGs 
(Jankowski et al., 2009).  Both CH-fibers in the 4-5 week group were IB4-negative and TRPV1-
positive (Table 6). 
 
Figure 5. Immunocytochemical and electrophysiological characterization of C-
polymodal (CPM) and C-heat (CH) afferents in the L2-3 DRG using the ex vivo 
preparation.  Sharp electrode recordings were made from a Neurobiotin(NB)-stained CPM 
cell (A-D) that had characteristic mechanical and thermal responses, bound IB4, and did not 
express TRPV1.  In contrast, a NB-stained CH neuron (E-H) responded only to heat, did not 
bind IB4, and stained positively for TRPV1. 
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Table 6. Acquisition of mechanical sensitivity in TRPV1+ CH neurons. NB-stained CPM 
and CH neurons in all three groups were characterized for IB4 binding and TRPV1-staining.  
In only the 4-5 week contralateral group were there any CPM fibers staining positively for 
TRPV1.  All stained CH fibers were positive for TRPV1 and negative for IB4-binding. 
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In order to determine if the increase in the prevalence of CH-fibers at 4-5 weeks and the 
appearance of TRPV1 polymodal fibers were correlated with any shift in the populations of IB4-
binding and TRPV1-expressing neurons in the ganglion, we immunohistochemically processed 
L3 DRGs from a group of uninjured mice and groups of mice at 2 weeks at 4-5 weeks following 
a contralateral saphenous nerve axotomy.  Here we found that no change in the number of 
TRPV1 or IB4 positive neurons after contralateral saphenous nerve section and regeneration 
(Figure 6).     
 
 
 
 
 
 
Figure 6. IB4 and TRPV1 staining in L3 DRG after contralateral injury.  There is no 
change in total TRPV1-staining or IB4-binding in the L3 DRG at 2 weeks and 4-5 weeks 
following contralateral saphenous nerve axotomy.   
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3.1.7 Skin innervation patterns are not affected by increased expression of neurotrophic 
factors in the contralateral skin 
In order to investigate whether the increase in neurotrophic factor expression in the skin 
contralateral to the nerve injury affected the cutaneous innervation, we used PGP9.5 staining to 
measure innervation density.  We found that innervation density as measured in percentage of 
area staining positively for PGP9.5 was unchanged at 14 days (2.1% ±0.4%) or 28 days (2.5% 
±0.5%) after contralateral saphenous nerve axotomy when compared to naïve controls (1.9% 
±0.6%).  A representative section of skin from each condition is shown in Fig. 7. 
 
 
 
Figure 7. PGP9.5 staining of dorsal hairy hindpaw sections from control and 
contralateral axotomy groups. Dermal and epidermal innervations patterns at 14 days (A) 
and 28 days (B) following contralateral saphenous nerve axotomy are similar to those seen in 
uninjured mice. 
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3.2 THE ROLE OF INCREASED P2Y1 EXPRESSION IN THE HEAT THRESHOLD 
REDUCTION OF C-POLYMODAL AFFERENTS 4-5 WEEKS AFTER 
CONTRALATERAL INJURY 
 
As discussed in the introduction, previous work has shown that the overexpression of 
neurotrophins and neurotrophic factors can alter the sensitivity of sensory neurons and that this 
may be mediated by enhanced expression of associated ion channels and receptors in the DRGs 
(Stucky et al., 1999; Albers et al., 2006; Elitt et al., 2006; McIlwrath et al., 2007; Lawson et al., 
2008).  Having identified here that there is enhanced cutaneous expression of GDNF in the hairy 
skin innervated by the saphenous nerve after contralateral injury, we focused our attention on 
P2Y1, which was significantly upregulated at the timepoint (28d) when we observed a heat 
threshold reduction in CPM fibers.  P2Y1 has been shown to significantly colocalize with the 
GDNF-sensitive IB4-binding population (Bradbury et al., 1998; Ruan and Burnstok, 2003; Malin 
and Molliver, 2010), and P2Y1 has been implicated in regulating thermal sensitivity of CPM 
fibers following inflammation (Malin et al., 2008; Molliver et al., 2011; Jankowski et al., 2012).  
Here we hypothesized that increased DRG expression of P2Y1 was essential for the CPM heat 
threshold reduction at 4-5 weeks after contralateral injury, and we used an siRNA-mediated 
knockdown strategy to investigate this further. 
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3.2.1 In vivo inhibition of contralateral injury-induced P2Y1 expression 
To block the contralateral injury-induced upregulation of P2Y1, we used P2Y1-targeting 
(PenY1) siRNAs injected into the saphenous nerve at 14d and 21d after axotomy of the 
contralateral saphenous nerve.  Control-injected mice were injected at the same timepoints as 
PenY1 mice.  As discussed in section 2.5, we determined that this injection paradigm produced 
significant knockdown of P2Y1 mRNA in a cohort of adult SW mice at 28d after contralateral 
saphenous nerve axotomy.  We found that P2Y1 gene expression could be specifically inhibited 
by PenY1 injection using 6 mice in the PenY1 group and 6 PenCON controls. At 28 days 
following contralateral injury, P2Y1 mRNA was found to be significantly increased in the DRG 
after injection of control, nontargeting (PenCON) siRNA (42% ± 17%), while injection of 
targeting PenY1 siRNA significantly inhibited the contralateral injury-induced increase in P2Y1 
mRNA (-5% ± 16%) (Fig. 8).  Results obtained from reverse transcription PCR analysis were 
then verified at the protein levels (Contralateral saphenous nerve axotomy (28d) (vs. uninjured 
controls): 75% ± 12%; PenCON + contralateral saphenous nerve axotomy (28d): 90% ± 20%; 
PenY1 + contralateral saphenous nerve axotomy (28d): 10% ± 18%) (Fig. 9).  
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In order to determine whether the inhibition of P2Y1 expression was selective, we also 
analyzed the expression of several additional genes following siRNA-targeted knockdown.  First, 
we examined the expression of the ATP receptor P2X3. mRNA P2X3, which was upregulated in 
the L2,3 DRGs at 28 days after contralateral injury, was similarly increased following control 
and P2Y1 targeting siRNA injections at 28 days after contralateral injury (Contra saph cut (28d):  
66% ± 20%; PenCON + contra saph cut (28d): 52% ± 12%; PenY1 + contra saph cut: 49% ± 
20%). Next we analyzed the expression of TRPV1, which was significantly upregulated at 28 
days following contralateral nerve injury (49% ± 20%) (Fig 10).  Following the injection of 
P2Y1-targeting and control siRNAs, we found that TRPV1 was significantly 
  
Figure 8. P2Y1 mRNA knockdown.  P2Y1-targeting siRNAs injected into the intact 
saphenous nerve at 14d and 21d following contralateral saphenous nerve axotomy blocks 
increased mRNA expression of P2Y1.  
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increased  (PenCON + contra saph cut (28d): 51% ± 16%; PenY1 + contra saph cut (28d): 47% ± 
17%) (Fig. 10).  We also analyzed mRNA levels of GFRα3, whose expression was not 
significantly altered at 28d after contralateral injury (13% ± 25%). Injection of P2Y1-targeting 
and control siRNAs revealed no change in GFRα3 mRNA levels (PenCON + contra saph cut 
(28d): 15% ± 22%; PenY1 + contra saph cut (28d): 3% ± 21%) (data not shown). 
 
 
 
 
 
 
Figure 9.  P2Y1 protein knockdown. Western blot analysis of pooled L2,3 DRG 
samples showed that PenY1 is able to block the contralateral injury-induced upregulation 
of P2Y1 protein. 
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3.2.2 Characterization of primary afferents in the intact saphenous nerve following P2Y1 
knockdown at 4-5 weeks after contralateral saphenous nerve axotomy 
A total of 147 primary cutaneous neurons were intracellularly recorded and physiologically 
characterized from age-matched adult Swiss-Webster mice (n=28) from 28 days to 35 days 
following axotomy of the left (contralateral) saphenous nerve.  Of these 28 mice, 15 were 
injected with P2Y1-targeting siRNAs at 14d and 21d after contralateral injury, and 13 were 
injected with control siRNAs.  The results from these two experimental groups were compared 
with each other, to the contralateral injury group discussed in section 3.1, and to previously 
published results from naïve Swiss-Webster mice (Jankowski et al., 2009a). 
Figure 10. Off-target effects of PenY1 injection. Messenger RNA levels of P2X3 and 
TRPV1 are unaffected by PenY1 injection.  These results suggest that off-target effects of the 
P2Y1-targeting siRNAs are minimal. 
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3.2.3 P2Y1 knockdown blocks the contralateral injury-induced decreased in CPM heat 
thresholds 
Mice injected with control siRNAs into the intact saphenous nerve had CPM heat 
thresholds which were significantly reduced (38.2°C ± 1.0°C) (P = 0.01) compared to previous 
naïve mouse data (42.6°C ± 0.5°C) (Fig. 11).  However, inhibition of P2Y1 with P2Y1-targeting 
siRNA injections resulted in significantly higher thermal thresholds (41.7°C ± 0.9°C; P < 0.05 
vs. PenCON mice, p=0.3 vs naïve mice) (Fig. 11).  Additionally, heat thresholds of CPM 
neurons from mice that received P2Y1 siRNA at this time point were not statistically different 
from naïve CPMs, (p=0.3 vs naïve mice).  In agreement with data from Section 3.1, CPM mean 
firing rates were not changed in either PenCON or PenY1 mice.  We also determined the peak 
instantaneous firing rate of CPM neurons to heat and found no differences in firing rate in either 
experimental group.  Although we previously showed that P2Y1 knockdown reduced cold 
thresholds in CPM fibers responding to cold (Jankowski et al., 2011), we did not observe any 
change in CPM cold thresholds in PenCON or PenY1 mice (Naïve: 16.6°C ± 0.6°C; PenCON + 
contra saph cut (4-5 wks): 17.7°C ± 1.8°C; PenY1 + contra saph cut (4-5 wks): 15.0°C ± 1.4°C), 
though PenY1 mice approached significance vs. naives (p=0.1).  CPM mechanical thresholds 
were not altered in either PenCON or PenY1 mice (Naïve: 21.2 mN ± 2.2 mN; PenCON + contra 
saph cut (4-5 wks): 19.4 mN ± 4.1 mN; PenY1 + contra saph cut (4-5 wks): 17.4 mN ± 4.2 mN).  
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Figure 11.  CPM heat thresholds after PenY1 injection: In PenY1-injected mice, mean heat 
thresholds in characterized CPM fibers were significantly higher than in control-injected mice 
and approached heat thresholds seen in CPM fibers from naïve mice.  *p<0.05 vs. Uninjured 
mice, One-way ANOVA, Tukey’s post hoc test.  
 
* 
* 
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3.2.4 P2Y1 knockdown does not affect recruitment of CH neurons induced by 
contrslateral injury 
The heat thresholds of TRPV1-immunopositive, IB4-negative CH fibers in both the 
PenCON (39.9 ± 3.3 °C) and PenY1 (40.2 ± 4.1 °C) groups were not statistically different from 
naives (41.0 ± 1.6 °C).  In addition, both control-injected and PenY1-injected mice had 
significantly increased overall CH prevalence at 4-5 weeks following contralateral injury 
(PenCON + contra saph cut (4-5 wks): 26%, p<0.05, Fisher’s Exact Test; PenY1 + contra saph 
cut (4-5 wks: 19%, p<0.05, Fisher’s Exact Test) when compared to naïve mice (4% CH 
prevalence) (Fig. 12). A similar significant increase in CH fiber prevalence was also found in 
regenerated CH fibers after saphenous nerve axotomy (Jankowski et al., 2009). Thus, the 
injection of PenCON and PenY1 siRNAs had no effect on the normal increase in CH prevalence 
of cutaneous fibers following contralateral nerve injury.  The decrease in overall C-mechano 
prevalence found in the 4-5 week contralateral injury group (2% prevalence vs. 18% in naïve 
controls) was not evident in either injection group, surprisingly, as CM prevalence was 8% for 
PenCON mice and 9% for PenY1 mice.  Statistically, however, the CM prevalence in the 
injected groups was neither different from naives (p=0.3 for PenCON, p=0.4 for PenY1) or the 
4-5 week contralateral axotomy group (p=0.2 for PenCON, p=0.3 for PenY1). 
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3.2.5 Immunohistochemical characterization of CPM and CH neurons following and 
P2Y1 knockdown at 4-5 weeks after contralateral saphenous nerve axotomy  
A total of 16 cutaneous C fibers were intracellularly labeled, recovered for processing, and 
immunohistochemically characterized in the injected mice.  Among control siRNA injected 
mice, nearly all (6/7, 86%) of stained CPM fibers bound IB4, while one CPM fiber stained mice, 
nearly all (6/7, 86%while one CPM fiber stained positively for TRPV1 (14%) (Table 5).  The 
presence of TRPV1+ CPM fibers in both groups follows what is seen in the 4-5 week 
contralateral injury mice (from section 3.1) and in regenerated fibers (Jankowski et al., 2009).  
Figure 12. CH recruitment after PenY1 injection.  Recruitment of CH neurons at 4-5 
weeks after contralateral injury is not affected by knockdown of P2Y1 expression. There was 
still a statistically significant increase in the proportion of recorded CH-fibers in both 
PenCON and PenY1 mice vs. uninjured mice.  Significance is indicated as p<0.05 (*), 
Fisher’s exact test vs. uninjured mice. 
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Two out of three (67%) stained CH fibers in the PenCON group were positive for TRPV1, and 
Figure 13. IB4 and TRPV1 staining in PenY1 mice and controls.  PenCON and PenY1 
mice show no change in total TRPV1-staining or IB4-binding in the L3 DRG at 4-5 weeks 
following contralateral saphenous nerve axotomy.  
Table 7. NB-stained characterized C-fibers in PenY1 and PenCON mice.  NB-
stained CPM fibers staining positively for TRPV1 are evident in both PenCON and 
PenY1 mice at 4-5 weeks following contralateral saphenous nerve axotomy. All 
stained CH fibers were negative for IB4, and all but one was TRPV1-
immunopositive. 
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Two out of three (67%) stained CH fibers in the PenCON group were positive for TRPV1, and 
none bound IB4.  In PenY1 mice, 3/4 (75%) CPM fibers bound IB4, and 1/4 (25%) was 
TRPV1+.  Of the two stained CH fibers in the PenY1 group, both were positive for TRPV1.  
Although the total number of characterized stained cells in these groups was fairly small, the data 
generally agree with data from mice only receiving a contralateral injury, suggesting that P2Y1 
upregulation is not essential for the observed shift in phenotype.  We looked at whole DRG 
staining for IB4 and TRPV1 in the injected groups to determine if there was any shift in the total 
number of neurons in each population.  Our analysis revealed that the appearance of TRPV1+ 
CPM fibers is apparently not due to de novo TRPV1 expression, as there was no difference in the 
numbers of TRPV1-containing DRG neurons in either group when compared to naïve controls 
and the contralateral injury (28d) group (Naïve: 33.1 ± 2.1; PenCON + contra saph cut (28d): 
30.8 ± 2.6; PenY1 + contra saph cut (28d): 33.0 ± 2.7) (Fig. 13).  Total IB4 binding was also 
unaffected under any condition (Naïve: 34.5 ± 2.5; PenCON + contra saph cut (28d): 31.2 ± 2.4; 
PenY1 + contra saph cut (28d): 28.4 ± 3.2).  (Fig. 13).   
 
 
 
 
 
 
 
 
 66 
3.3 THE ROLE OF INCREASED TRPV1 EXPRESSION IN THE RECRUITMENT 
OF C-HEAT FIBERS AT 4-5 WEEKS AFTER CONTRALATERAL INJURY 
Having shown that enhanced P2Y1 expression was essential for the CPM heat threshold 
reduction in intact saphenous afferents after contralateral nerve injury, we hypothesized that 
TRPV1 upregulation had a critical role in the increase in overall CH prevalence at the 4-5 week 
timepoint after contralateral injury.  We showed that cutaneous Artemin was significantly 
increased in message and in protein by 14d, and nearly 99% of cells expressing the Artemin 
receptor GFRa3 also express TRPV1 (Orozco et al., 2001; Elitt et al., 2006), which was 
significantly upregulated in the contralateral L2,3 DRGs at 28d after contralateral injury.  
Moreover, nearly all CH neurons in mice express TRPV1 (Lawson et al., 2008).  In the following 
experiments, we targeted TRPV1 upregulation using TRPV1-targeting siRNAs in order to 
investigate whether increased TRPV1 expression is required for the CH recruitment we 
observed. 
3.3.1 Confirmation of TRPV1 mRNA knockdown with TRPV1-targeting siRNA  
In order to investigate the role of increased TRPV1 expression in the functional changes 
observed at 4-5 weeks after contralateral saphenous nerve axotomy, we used TRPV1-targeting 
siRNAs injected into the intact saphenous nerve to confirm that we could effectively block the 
TRPV1 mRNA upregulation. At 28 days following contralateral injury, TRPV1 mRNA was 
found to be significantly increased in the DRG after injection of control, nontargeting (PenCON) 
siRNA (47% ± 8%; Fig. 14). Injection of targeting PenV1 siRNA significantly inhibited the 
contralateral injury-induced increase in TRPV1 mRNA (-10% ± 8%) (Fig. 14).  We attempted 
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several TRPV1 Western blot assays of L2,3 DRG protein with several different protein isolation 
techniques and antibodies but did not identify a protocol that produced reliable, reproducible 
data.  
We analyzed mRNA levels of a number of other genes to determine the selectivity of 
TRPV1 knockdown.  We performed RT-PCR analysis of P2Y1, primarily expressed on 
nonpeptidergic afferents, and P2Y2, which is highly expressed in TRPV1+ neurons.  P2Y1, 
which was upregulated in the L2,3 DRGs at 28 days after contralateral injury, was similarly 
increased following control and TRPV1 targeting siRNA injections at 28 days after contralateral 
injury (Contra saph cut (28d):  55% ± 10%; PenCON + contra saph cut (28d): 53% ± 5%; PenV1 
+ contra saph cut: 44% ± 8%) (Fig 14). Next we analyzed the expression of P2Y2, which was 
significantly upregulated at 28 days following contralateral nerve injury (55% ± 18%) (Fig. 14) 
and which has been shown to be critical for thermal nociception and function of TRPV1 (Malin 
et al., 2008).   
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Figure 14. Effect of PenV1 on TRPV1, P2Y1, and P2Y2 mRNA. TRPV1-targeting 
siRNA (PenV1) can block the contralateral injury-induced upregulation of TRPV1 but does 
not affect P2Y1 and P2Y2 upregulation. The results suggest that off-target effects of PenV1 
are minimal. *p<0.05 vs. PenCON + contra saph cut. 
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Following the injection of TRPV1-targeting and control siRNAs, we found that P2Y2 
was still significantly increased (PenCON + contra saph cut (28d): 59% ± 18%; PenV1 + contra 
saph cut (28d): 49% ± 12%) (Fig. 14).  As in the previous section, we also analyzed mRNA 
levels of GFRα3, whose expression was not significantly altered at 28d after contralateral injury 
(13% ± 25%) and whose increased expression was shown to be critical for CH recruitment after 
nerve injury (Jankowski et al., 2010). Injection of TRPV1-targeting and control siRNAs revealed 
no change in GFRα3 mRNA levels (PenCON + contra saph cut (28d): 15% ± 7%; PenV1 + 
contra saph cut (28d): -6% ± 9%) (data not shown).   
3.3.2 Characterization of primary afferents after TRPV1 knockdown at 4-5 weeks 
following contralateral saphenous nerve axotomy 
A total of 116 primary cutaneous neurons were intracellularly recorded and physiologically 
characterized from 29 nerve injured Swiss-Webster mice (PenCON: n=13; PenV1: n=16). Of the 
characterized cells, 53 cells came from mice that received nerve cut of the left saphenous nerve 
plus control (PenCON) siRNA injection into the right saphenous nerve 14d post-injury.  The 
remaining 63 cells came from mice that received nerve cut of the left saphenous nerve plus 
TRPV1-targeting (PenV1) siRNA injection into the right saphenous nerve 14d post-injury. The 
results from these experimental groups were compared with one another and to the mice 
described in Section 3.1 (contralateral injury only), as well as previously published results from 
naive SW mice (Jankowski et al., 2009a). 
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3.3.3 TRPV1 knockdown does not affect the CPM heat threshold reduction normally seen 
at 4-5 weeks after contralateral saphenous nerve axotomy 
In PenCON and PenV1 mice, CPM heat thresholds were significantly reduced (PenCON 
+ contra saph cut (4-5 wks): 38.9 ± 0.9°C, p<0.01; PenV1 + contra saph cut (4-5 wks): 39.4 ± 
0.8°C (p<0.01) compared to previous naive mouse data (42.6 ± 0.5°C) (Fig 15). CPM mean 
firing rates to heat were not changed in either PenCON or PenY1 mice.  We also determined the 
peak instantaneous firing rate of CPM neurons to a heat ramp and found no differences in firing 
rate in either experimental group.  As seen in the PenY1/PenCON mice, we did not observe any 
change in CPM cold thresholds in PenCON or PenY1 mice (Naïve: 16.6°C ± 0.6°C; PenCON + 
contra saph cut (4-5 wks): 17.5°C ± 2.7°C; PenV1 + contra saph cut (4-5 wks): 16.4°C ± 1.9°C).  
CPM mechanical thresholds were not altered in either PenCON or PenV1 mice (Naïve: 21.2 mN 
± 2.2 mN; PenCON + contra saph cut (4-5 wks): 16.9 mN ± 4.7 mN; PenV1 + contra saph cut 
(4-5 wks): 19.1 mN ± 3.2 mN).  In summary, TRPV1-targeting siRNA injections had no 
apparent effect on the response properties of CPM fibers after contralateral injury. 
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Figure 15.   CPM heat thresholds in PenV1 mice and controls.  Knockdown of TRPV1 
expression with PenV1 does not affect the CPM heat threshold reduction normally seen at 4-5 
weeks after contralateral injury. *(p<0.05 vs uninjured controls, One-way ANOVA, Tukey’s 
post hoc test). 
 
* * * 
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3.3.4 TRPV1 knockdown blocks the recruitment of newly functional CH fibers at 4-5 
weeks following contralateral injury 
As in the PenY1/PenCON experiments, the heat thresholds of CH fibers in both the PenCON 
(41.9 ± 3.0 °C) and PenV1 (41.0 ± 3.6 °C) groups were not statistically different from naives 
(41.0 ± 1.6 °C).  CH fibers here also showed no significant changes in thermal threshold or firing 
rate in either condition. However, the prevalence of CH fibers significantly decreased 
significantly after PenV1 injection (9%) vs. 21% seen in PenCON mice (Fig. 16) and 20% seen 
in the 4-5 week contralateral injury group (Fig. 16).  The difference in CH prevalence between 
PenCON and PenV1 mice is statistically significant (p=0.04, Fisher’s Exact Test).  Surprisingly, 
Figure 16.  PenV1 injection blocks CH recruitment.  Knockdown of TRPV1 expression 
with PenV1 almost completely blocks CH neuron recruitment seen at 4-5 weeks after 
contralateral injury. There was still a statistically significant increase in the proportion of 
recorded CH-fibers in PenCON mice vs. uninjured mice.  * p<0.05, Fisher’s exact test vs. 
uninjured mice.  PenV1 mice also had an increase in CM prevalence to a level normally 
seen in uninjured mice. 
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we also saw that PenV1 injection reversed the reduction in overall C-mechano prevalence to 
levels seen in uninjured mice (19% in PenV1 mice vs. 18% in naïve controls) (Fig 16).  In 
summary, PenV1 injection blocked CH neuron recruitment and the reduction in CM prevalence 
after contralateral nerve injury. 
 
3.3.5 Neurochemical identity of CPM and CH neurons after TRPV1 knockdown at 4-5 
weeks following contralateral saphenous nerve axotomy 
A total of 16 cutaneous C-fibers were intracellularly labeled, recovered, and 
immunohistochemically characterized in nerve-injured mice from the PenCON and PenV1 
groups.  In PenCON mice, the only stained CH fiber was TRPV1+ and did not bind IB4 (Table 
5).  In CPM fibers in PenCON mice, 2/3 were IB4+ and 1/3 (33%) was TRPV1+, similar to what 
was observed in the 4-5 week contralateral injury group (Table 8). In PenV1 mice, 4/4 CH fibers 
stained positively for TRPV1 and did not bind IB4 (Table 8).  6/8 stained CPM fibers in the 
PenV1 group were IB4+, TRPV1-, but one fiber was IB4-, TRPV1+.  The overall number of 
stained cells here is too few to find any significant difference relative to uninjured mice, but it is 
still an important finding that we see TRPV1+ CPM fibers in both experimental groups, since we 
see them at 4-5 weeks following contralateral injury and have not observed any in naïve mice.  
These results suggest that TRPV1 upregulation is not essential for the apparent shift in 
phenotype of these TRPV1+ cells.   
Since TRPV1-targeting siRNA effectively blocked the recruitment of CH neurons at 4-5 
weeks following contralateral injury, we sought to determine if total TRPV1 staining in the DRG 
was affected by PenV1 injection.  Although we saw no change in total TRPV1 or IB4 staining 
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after contralateral injury alone, we wanted to determine if PenV1 was able to alter the total 
number of neurons in the TRPV1+ and IB4+ populations, respectively.  Confocal analysis 
revealed no difference in the numbers of TRPV1-containing DRG neurons in either group when 
compared to naïve controls and the contralateral injury (28d) group (Naïve: 33.1 ± 2.1; PenCON 
+ contra saph cut (28d): 30.1 ± 1.8; PenV1 + contra saph cut (28d): 29.5 ± 2.0) (Fig 17).  Total 
IB4 binding was also unaffected under either condition (Naïve: 34.5 ± 2.5; PenCON + contra 
saph cut (28d): 30.3 ± 2.5; PenV1 + contra saph cut (28d): 30.7 ± 2.3).  (Fig 17).  
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Figure 17. IB4 and TRPV1 staining in L3 DRGs from PenV1 and control mice. There 
was no change in total TRPV1-staining or IB4-binding in the L3 DRG at 4-5 weeks following 
contralateral saphenous nerve axotomy in either PenV1 or PenCON mice. 
 
Table 8. NB-stained characterized C-fibers in PenV1 and PenCON mice.  CPM fibers 
staining positively for TRPV1 are evident in both PenCON and PenV1 mice at 4-5 weeks 
following contralateral saphenous nerve axotomy.  
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4.0  GENERAL DISCUSSION 
The data presented here demonstrates that a unilateral nerve injury resulted in increased mRNA 
expression of several neurotrophic factors in the uninjured, contralateral skin. The specific 
neurotrophic factors, including members of the NGF and GDNF families, and the regions of skin 
affected were largely the same as seen in the nerve injured side (Jankowski et al, 2009a).  We 
found that protein expression of two neurotrophic factors, GDNF and Artemin, was similarly 
increased in the skin innervated by the contralateral saphenous nerve at 14d following injury.   
The increase in GDNF protein was surprising since we did not see a significant mRNA 
increase until the 21d timepoint.  Our data at the 14d timepoint showed a mean 30% increase in 
GDNF mRNA levels, but the error associated with the measurement was nearly equal in 
magnitude, suggesting that if there were a small increase in GDNF mRNA levels, it might be 
very difficult to detect.  The result may simply mean that very small upregulation of GDNF 
mRNA is sufficient to produce robust increases in protein expression.  It may also suggest that 
other mechanisms such as translational regulation and protein degradation may have 
significantly affected GDNF protein expression.  Repeating the experiment at the same timepoint 
with additional mice might shed some light on how such a dramatic increase in GDNF protein 
occurs without us observing changes in mRNA.  It is also possible that GDNF is not a gene 
whose mRNA expression correlates well with protein expression.  It is established that mRNA 
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and protein levels do not necessarily correlate.  Studies of steady state protein and mRNA levels 
of several hundred genes in cell culture lines including mouse EML (Tian et al., 2004) and 
human medulloblastoma cells (Vogel et a., 2010) found that mRNA and protein had a correlation 
coefficients of only 0.41 and 0.29, respectively.  These studies point to the importance of 
translational regulation, protein stability, and protein degradation in determining absolute protein 
levels and that mRNA may not always be an appropriate surrogate for protein levels.   
The enhanced levels of neurotrophic factors were correlated with increased expression of 
several associated receptor proteins and ion channels in the DRGs, including several nucleotide 
receptors, TRP channels, and GFL receptors, similar to changes observed on the ipsilateral side 
following saphenous nerve axotomy and regeneration (Jankowski et al., 2009a).  This increased 
expression was also correlated with significant changes in the functional response properties of 
sensory neurons in the intact nerve, many of which mirror changes observed following 
saphenous nerve regeneration (Jankowski et al., 2009).  Specifically, the degree of heat threshold 
reduction in the CPM population in the 4-5 week group and the apparent recruitment of 
previously unresponsive TRPV1-positive, CH neurons are nearly identical to that seen in the 
injured nerve 4-6 weeks following transection.  Likewise, we found that some TRPV1+ CH 
fibers appeared to gain mechanical sensitivity as in the ipsilateral side (Jankowski et al., 2009).  
None of these changes were evident in the contralateral nerve at 2 weeks, despite upregulation of 
artemin and several other neurotrophins and neurotrophic factors as early as 7d post-axotomy.  
Together, these data suggest that prolonged exposure of sensory neurons to upregulated 
endogenous expression of neurotrophic factors can induce phenotypic changes as well as 
sensitization in subsets of intact cutaneous nociceptors. 
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4.1 POTENTIAL MECHANISMS OF SYMMETRICAL CHANGE IN CUTANEOUS 
EXPRESSION OF TROPHIC FACTORS 
Numerous mechanisms have been proposed to explain the emergence of contralateral changes 
observed in clinical and animal studies, including changes in the peripheral or central nervous 
systems.  Specific peripheral mechanisms suggested include sensitization of contralateral 
afferents by humoral factors and transmedian sprouting of contralateral neurons near structures 
that receive bilateral innervation following a unilateral nerve injury (Koltzenburg et al., 1999).  
Proposed central mechanisms include overlapping central terminals of homologous structures, 
whereby unilateral injury could then communicate to the contralateral side, and communication 
in the spinal cord and brainstem via commissural interneurons, through direct neuronal activation 
or release of specific factors to contralateral neurons (Koltzenburg et al., 1999).  Most studies 
provide evidence in favor of central mechanisms over peripheral ones.  For example, heat injury-
induced contralateral hyperalgesia was not blocked by ipsilateral C-fiber afferent blockade but 
was prevented by spinal anesthesia or blockade of sympathetic efferents (Coderre and Melzack, 
1987), and neither blockade of C-fiber afferent input nor dorsal rhizotomy affected the 
mechanical hyperalgesia evident in the contralateral hindlimb following unilateral intramuscular 
injection of acidic saline (Sluka et al., 2001).  Additionally, spinal dorsal horn neurons and 
thalamic neurons demonstrated increased response to mechanical stimulation of the contralateral 
hindlimb after unilateral injection of acidic saline (Sluka et al., 2001).  As described earlier, 
another study showed that descending facilitatory pathways from the rostral ventral medulla 
(RVM) were responsible for initiating and maintaining bilateral hyperalgesia after unilateral 
intramuscular injection of acidic saline (Tillu et al., 2008).  Furthermore, both bilateral 
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mechanical allodynia resulting from a unilateral sciatic nerve inflammation was reversed by 
intrathecal delivery of glial metabolic inhibitor and proinflammatory cytokine antagonists 
specific for interleukin-1, tumor necrosis factor, or interleukin-6, suggesting that glial and 
proinflammatory cytokine actions in the spinal cord are critical for the maintenance of mirror 
image pain (Milligan et al., 2003). 
In the data presented here, the increased cutaneous expression of neurotrophic factors 
does not appear to be part of a widespread, systemic upregulation, though there were increases in 
the expression of Artemin in the hairy thigh skin bilaterally and of GDNF and Neurturin in the 
ipsilateral thigh.  Although we have not identified the source of these changes, it is possible that 
the incision in the thigh skin during axotomy results in a local increase in cutaneous neurotrophic 
factor expression and a similar one in the mirror opposite thigh skin.  The anatomical specificity 
of these results suggests that the contralateral effects are not the result of a systemic phenomenon 
but rather a specific neural mechanism involving the CNS.  Additional support for the specificity 
of contralateral changes following peripheral injury comes from human studies where unilateral 
capsaicin injections elicited mirror symmetric mechanical hyperalgesia in the several subjects 
(Shenker et al., 2008).  In a second study (Lei et al., 2008), it was shown that intramuscular 
injections of hypertonic saline into the tibialis anterior muscle elicited symmetric changes in 
cutaneous blood flow which matched areas of perceived pain.  In both of these studies, the 
changes were observed within an hour of the peripheral injections.  Such rapid and precise 
bilateral communication also suggests that central neural mechanisms are involved. 
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4.2 EFFECTS OF ENHANCED NEUROTROPHIC FACTOR LEVELS ON C-
POLYMODAL FIBERS 
The decrease in heat thresholds of the non-peptidergic, IB4-binding CPM population correlated 
with upregulation of cutaneous GDNF and its receptor GFRα1 in the DRGs. In addition to 
GFRα1, IB4-binding C-fibers also contain the ADP receptor P2Y1, which was also upregulated 
following contralateral nerve cut.  P2Y1 has been shown to be essential for normal thermal 
sensitivity of cutaneous CPM neurons (Molliver et al., 2011). In addition, we have also recently 
shown that increased P2Y1 expression following cutaneous inflammation is essential for the 
observed decrease in CPM heat thresholds (Jankowski et al., 2012).  Although the precise 
intracellular signaling mechanisms downstream of GDNF-GFRα1 leading to the increased 
expression of these genes is unknown, the evidence obtained here suggests that the cutaneous 
upregulation of GDNF, along with increased expression of GFRα1 and P2Y1 may be involved in 
the sensitization of intact CPM fibers to heat after contralateral nerve injury. 
In addition to heat threshold reduction of CPM fibers, there was a significant decrease in 
the prevalence of CM fibers.  Previously we have shown that the majority of CM fibers are 
nonpeptidergic, bind IB4, and contain the mas gene related G-protein coupled receptor Mrgprd 
(Lawson et al., 2008; Rau et al., 2009).  Thus, many of these fibers would also contain GFRα1 
and be sensitive to GDNF.  This reduction in the prevalence of CM fibers (18% - 2%) is almost 
identical to the results of our previous study of transgenic mice overexpressing GDNF in the 
skin, where the prevalence of CM fibers in wildtype mice (19%) was reduced to 3% in 
transgenic mice (Albers et al., 2006). Taken together, these findings suggest the possibility that 
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cutaneous GDNF levels and signaling through GFRα1 could alter phentoype of these cells by 
regulating the ability of this population of C-fibers to respond to heat.  
 
4.3 EFFECTS OF ENHANCED TROPHIC FACTOR LEVELS ON CUTANEOUS 
CH-FIBERS 
The major functional change observed in the population of peptidergic fibers was a significant 
increase in the prevalence of CH neurons at 4-5 weeks after contralateral injury.  In an earlier 
study (Christianson et al. 2006), it was shown that the percentage of TRPV1-expressing 
cutaneous neurons in the L2-3 DRGs is significantly higher (~15-20%) than the percentage of 
functional TRPV1-expressing CH neurons (~5%). This would suggest that in naïve mice many 
cutaneous fibers containing TRPV1 do not respond to heat or mechanical stimuli.  Increased 
cutaneous levels of Artemin and possibly NGF may lead to the acquisition of heat sensitivity in 
these TRPV1-positive neurons.  
These results are very similar to that seen following regeneration (Jankowski et al., 
2009), and we have shown that this change in phenotype is dependent on increased expression of 
GFRα3 (Jankowski et al., 2010).  Although GFRα3 expression is unchanged in the L2-3 DRGs 
contralateral to the injury, it is possible that the increase in cutaneous Artemin is sufficient to 
increase GFRα3 signaling in the DRG.  It is also possible that GFRα3 expression is increased, 
but only in the small subset of CH-fibers and that this change is not detectable at the whole DRG 
level.  This difference between ipsilateral and contralateral expression could be due to the fact 
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that there is a profound increase in DRG neurons expressing GFRα3 following injury (Bennett et 
al., 2000).  We also observed a significant upregulation in the expression of the purinergic 
receptor P2Y2, which has been shown to colocalize with TRPV1 in sensory neurons and is a 
critical contributor to TRPV1 function and thermal nociception (Malin et al., 2008). Thus, 
increased levels of P2Y2 may also be involved in the plasticity of TRPV1-expressing afferents.  
The other apparent change in this population was the appearance of a population of fibers 
that stained positively for TRPV1 and responded to both heat and mechanical stimuli.  This 
change in phenotype is similar to that seen following regeneration (Jankowski et al., 2009) and 
inflammation (Koerber et al., 2010). As in the previous studies, this change was apparently not 
due to an increase in the total number of TRPV1 expressing neurons, as TRPV1 staining in each 
of the experimental groups was not different from naïve animals.  Additional support for such a 
phenotypic switch is the lack of IB4 staining in these cells.  However, we still do not understand 
the mechanisms of how this population of peptidergic TRPV1+ neurons may acquire mechanical 
sensitivity.  Further study to better characterize the molecular expression profile and plasticity in 
these cells will be necessary. 
  
4.4 SKIN INNERVATION PATTERNS ARE UNCHANGED AFTER 
CONTRALATERAL NERVE INJURY 
Having identified that a number of target-derived neurotrophic factors have significantly 
increased cutaneous expression following contralateral nerve injury and that mice overexpressing 
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such neurotrophic factors as NGF (Stucky et al., 1999), NT-3 (Albers et al., 1996), and BDNF 
(LeMaster et al., 1999) have increased skin innervation, we sought to quantify the degree of skin 
innervation in the hairy hindpaw skin innervated by the intact contralateral saphenous nerve 
using PGP9.5 as a pan-neuronal marker.  Although we found significantly increased mRNA and 
protein expression of several cutaneous neurotrophic factors, there were no significant 
differences in innervation density between the experimental groups and naïve mice.  These 
findings would suggest that either the enhanced expression is relatively small when compared to 
levels seen in the transgenic mice or that ongoing, long-term exposure beyond the timeframe 
used in this study is essential for changing innervation density. 
 
 
4.5 INCREASED P2Y1 EXPRESSION IS ESSENTIAL FOR THE 
CONTRALATERAL INJURY-INDUCED HEAT THRESHOLD REDUCTION IN CPM 
FIBERS 
Utilizing an in vivo siRNA-mediated knockdown strategy, we were able to show that in intact 
saphenous afferents following contralateral nerve injury, PenY1 was able to block the 
upregulation of P2Y1, both in message and protein.  The siRNA-mediated knockdown of P2Y1 
upregulation did not have any significant effect on the mRNA expression of the other genes we 
studies, suggesting its action was P2Y1-specific.  PenY1 injection at 14 days and 21 days after 
contralateral saphenous nerve axotomy completely blocked the CPM heat threshold reduction 
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normally seen at 4-5 weeks after contralateral injury.  There was no effect of knockdown on 
mean firing rates to thermal stimuli or mechanical thresholds, similar to the effect of PenY1 
injection on the CFA-induced CPM heat threshold reduction (Jankowski et al., 2011).  These 
findings suggest that this ADP-binding G-protein-coupled receptor is important for regulating 
heat signaling in this specific type of cutaneous sensory neuron.  The specificity of the 
knockdown of P2Y1 mRNA and protein levels is an important consideration in the interpretation 
of these results.  One of the inherent risks with using a molecular tool like RNA interference is 
off-targeting effects of the siRNAs on other genes.  While it is not feasible to determine all 
possible off-target effects, we have determined that there were no effects on the expression other 
purinergic receptors (e.g. P2X3 and P2Y2) found in CPMs and other sensory neurons.  In 
addition, off-target effects are always a concern when utilizing RNAi techniques, as induction of 
RNAi in mammalian cells by expression of double-stranded RNA can activate innate antiviral 
response pathways that may produce off-target gene expression (Alvarez et al., 2006).  Previous 
studies in our lab, however, demonstrated that the Penetratin-linked siRNAs such as those used 
in the current experiments did not alter mRNA expression of interferon-inducible myxovirus 
resistance 2 (mx2) or interferon type I-induced and double-stranded RNA-activated kinase (IFN 
type I), indicating that these siRNAs did not activate the interferon viral response pathway 
(Jankowski et al., 2009b; Jankowski et al. 2010). 
Interestingly, PenY1 injection partially blocked the reduction in overall CM prevalence 
observed at 4-5 weeks following contralateral saphenous nerve axotomy but did not affect the 
CH recruitment normally seen.  We hypothesized earlier that the reduction in CM prevalence 
may in part be due to the acquisition of heat sensitivity in a population of CM fibers, so it is 
possible that increased P2Y1 expression is responsible for this shift in phenotype.  Our data in 
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the present studies and in Jankowski et al. (2012) has suggested that P2Y1 expression plays a 
critical role in altering the thermal thresholds of CPM fibers.  It is possible that some of the C-
mechanic fibers in naïve mice are in fact thermally sensitive but have heat thresholds beyond the 
range of temperatures we apply to the skin in our recording experiments.  Such a C-mechano 
fiber could become thermally sensitive once P2Y1 expression levels reached a certain threshold.  
If this were true, then the knockdown of P2Y1 might prevent some of this “acquisition” of heat 
sensitivity, resulting in CM prevalence values closer to naïve mice. Recent work has shown that 
P2Y1 is physically coupled to PKCα and may exert signaling mechanisms through their 
interaction (Shah et al., 2012).  This might be evidence that P2Y1 is less likely to be a heat 
transducer and more likely to regulate the expression or function of another heat transducer.  
Another possibility is that P2Y1 interacts with a mechanosensitive channel at the level of 
expression or function.  TRPM3 is a TRP channel family member that is expressed on small 
diameter neurons in the DRG and has been implicated in both thermal (Vriens et al., 2011) and 
mechanical (Inoue et al. 2009) sensation.  If TRPM3 were indeed a mechanosensor and its 
expression was negatively correlated with P2Y1 levels, then P2Y1-targeting siRNA might 
feasibly increase the prevalence of CM fibers.  Complicating this possible interpretation is that 
there was a nearly identical increase in CM prevalence in control siRNA-injected mice.  One 
possible explanation is that the two siRNA injections at 14d and 21d after contralateral injury 
resulted in damage to a population of fibers which might have limited or removed their access to 
elevated neurotrophic factor levels in the skin.  This might also explain why the reduction in CM 
prevalence was not affected in the control siRNA-injected mice in the PenV1 experiments, which 
had a single injection, rather than two. 
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It is notable the PenY1 group also showed a small, though not significant, increase in 
cold threshold, suggesting that P2Y1 expression is broadly involved in setting the thermal 
thresholds of polymodal C-fibers, not simply the heat thresholds.  This would agree with our 
findings of PenY1-mediated knockdown of P2Y1 in inflamed mice, which resulted in increased 
heat and decreased cold thresholds in CPM fibers (Jankowski et al., 2012).  Surprisingly, we saw 
no change in cold thresholds in mice at 4-5 weeks after contralateral injury, even though P2Y1 
was significantly upregulated, suggesting that the effect of P2Y1 in regulating cold sensitivity 
may have reached its ceiling.  Another possible interpretation is that PenY1 injection affected the 
expression of another gene or set of genes that may be involved in regulating the cold sensitivity 
of these afferent fibers.  These data also seem to support the notion that P2Y1 is not a heat or 
cold transducer but instead regulates the thermal threshold of a subset of C-fibers.   We still do 
not know what molecule or molecules may be transducing thermal stimuli in these fibers and 
what the functional interaction with P2Y1 might be.  TRPV3 in keratinocytes has been shown to 
use ATP as a signaling molecule in response to thermal stimulation (Mandadi et al., 2009), so 
this provides a potential mechanism by which P2Y1 and other nucleotide receptors might 
modulate the thermal responses of afferent fibers.  In these experiments, we found that both 
TRPV3 and TRPV4 mRNA were upregulated in the skin contralateral to injury, so it is possible 
that increased TRPV3 and/or TRPV4, together with upregulation of P2Y1, may be responsible 
for the altered thermal thresholds in CPM fibers. 
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4.6 INCREASED TRPV1 EXPRESSION IS ESSENTIAL FOR THE RECRUITMENT 
OF CH NEURONS FOLLOWING CONTRALATERAL NERVE INJURY 
 
Previous work has shown that enhanced artemin levels in the skin can regulate TRPV1 
expression in the DRGs (Elitt et al 2006).  Others and we have also previously shown that 
peripheral nerve axotomy increased artemin levels in the skin and increased levels of its receptor 
GFRα3 in the appropriate DRGs (Bennett et al 2000; Jankowski et al 2009a; 2010).  We recently 
showed that enhanced signaling through the artemin/GFRα3 pathway after regeneration caused 
changes in TRPV1 expression, leading to CH neuron recruitment (Jankowski et al., 2010).  In 
these experiments, we directly tested whether the increase in TRPV1 expression, in the absence 
of frank injury to the nerve itself, was associated with a specific functional change in the intact 
afferents.  We found that injection of Penetratin-1 conjugated, TRPV1-targeting siRNAs into the 
saphenous nerve could block the contralateral injury-induced increase in TRPV1 mRNA in the 
DRGs.  Here, we show that TRPV1 knockdown did not alter the contralateral injury-induced 
decrease in CPM heat threshold, but it was able to block the recruitment of CH neurons observed 
at 4-5 weeks after injury.  These results suggest that transient changes in TRPV1 have a critical 
role in regulating the properties of distinct populations of sensory neurons.  As described above, 
based on immunohistochemical staining of whole L3 DRGs at 28 days after contralateral injury, 
there is no change in the total number of IB4-binding or TRPV1-positive cells when compared to 
naïve mice.  The implication of this finding is that the “recruitment” of CH neurons would 
appear to come from a population of TRPV1-positive cells that do not respond to mechanical or 
thermal stimuli in naïve animals.  We cannot label these cells as functionally silent, as they may 
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still be chemosensitive, if not mechanically or thermally sensitive.  Given that TRPV1 
upregulation appears to be essential for CH recruitment, one plausible explanation is that 
increased TRPV1 expression in some of these neurons reaches a threshold at which point they 
become responsive to our heat stimulus.  Our results strongly suggest that changes in TRPV1 
expression are able to regulate the number of functional CH neurons in mice.  The ability to 
correlate TRPV1 expression levels with heat sensitivity at the single cell level may shed light on 
this possibility.   
 Among Neurobiotin-stained characterized cells, there were polymodal C-fibers in 
both the PenV1 and PenCON groups that stained positively for TRPV1, like those seen in the 
contralateral injury group at 4-5 weeks and the control injection groups.  This result is in 
agreement with our recent findings showed that TRPV1 knockdown did not affect the prevalence 
of TRPV1+ CPM neurons following nerve injury and regeneration.  We still do not know the 
mechanism by which these TRPV1+ afferents may acquire mechanical sensitivity.  Koizumu et 
al. (2004) showed that mechanical stimulation of cultured keratinocytes evoked release of ATP, 
a mechanism that might implicate P2Y2, which is highly expressed on TRPV1+ neurons and has 
been shown to be important for TRPV1 function, in mechanosensation in this peptidergic 
population.  Expression of P2Y2 was significantly increased after contralateral injury, and this 
increase was not affected by TRPV1 knockdown.   
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4.7 SUMMARY AND FUTURE DIRECTIONS 
The data presented here document mirror symmetric changes in the expression of neurotrophic 
factors in the skin and specific receptors and channels in the L2-3 DRGs following unilateral 
nerve injury.  These changes in expression are correlated with specific changes in the functional 
properties of cutaneous fibers in the intact saphenous nerve. These changes differ between the 
population of GDNF sensitive CPM fibers and the Artemin and NGF sensitive CH fibers.  These 
results show that endogenous upregulation of target-derived neurotrophic factors may lead to 
pronounced sensory neuron plasticity in intact sensory fibers, not simply those fibers subjected to 
injury or other pathology.  More specifically, we show that transient increases in P2Y1 and 
TRPV1 expression in the DRG are essential for the observed heat threshold reduction in 
polymodal C-fibers and the recruitment of CH neurons, respectively.  We know that the animals 
in these experiments are not truly “naïve,” but the fact that intact fibers exposed to increased 
expression levels of neurotrophic factors show similar increases in the expression of receptor 
proteins and ion channels in the DRG and exhibit many of the same functional changes as 
injured neurons suggests that the molecular changes potentiate this phenotypic change.  
Furthermore, although we have not directly studied pain with these experiments, evidence of 
neurotrophic factor-mediated sensitization of intact primary afferents contralateral to nerve 
injury provides an interesting mechanism by which mirror image pain might develop.  
Additionally, given that clinical nerve trauma does not always involve complete transection of 
the nerve fascicle, instead leaving intact fibers adjacent to damaged ones, these experiments can 
help us to understand how the properties of those intact fibers may change following nerve injury 
and how they might contribute to the development of neuropathic pain.   
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Of additional interest from a clinical perspective is our finding that some previously 
silent DRG neurons gain heat sensitivity and that some TRPV1+ CH fibers appear to acquire 
mechanical sensitivity at 4-5 weeks following contralateral nerve injury, similar to what was 
reported in regenerated nerves (Jankowski et al., 2009a).  Mechanically-insensitive, heat-
sensitive fibers have been identified in nonhuman primates (Baumann et al., 1991) and in 
humans (Schmidt et al., 1995).  The results here correlate with findings in patients with 
erythromelalgia, a neurovascular pain disorder, in which C-fibers with the biophysical properties 
of mechanically-insensitive afferents appeared to gain mechanical sensitivity (Ørstavik et al., 
2003).  Patients with diabetic neuropathy were also found to have a dramatic increase in the 
prevalence of mechanically-insensitive afferents (Ørstavik et al., 2006).  The similarity in CH 
recruitment and acquisition of mechanical sensitivity in CH neurons between the regenerated 
(Jankowski et al., 2009a) and uninjured contralateral saphenous nerve described here suggests 
that the target-derived neurotrophic factor signaling we have focused on may be important to the 
primary afferent plasticity observed in neuropathic pain disorders.   
Although many of the functional changes observed in the saphenous nerve at 4-5 weeks 
after contralateral axotomy mirror those changes seen in the regenerated nerve at a similar time 
point, these are not identical findings.  The intact contralateral saphenous nerve is exposed to 
increased levels of neurotrophic factors for a much longer period of time within that 4-5 week 
time frame, although it is possible that the injured nerve is also exposed to increased 
neurotrophic factor levels as it regenerates through the distal stump.   It may also be that 
although the mRNA changes in neurotrophic factor expression in the contralateral skin appeared 
similar to that seen in the ipsilateral skin, significant differences in protein levels may exist.  Our 
Western blot analysis of GDNF and Artemin protein in the skin innervated by the intact 
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saphenous nerve showed a similar increase relative to naive mice to what was observed on the 
injured side, but this analysis was done at 14d after injury, and the symmetry may not hold at 
later time points.  The similarities and differences between the injured and contralateral sides 
may provide important insight into the differential behavior of neurotrophic factor expression on 
injured and intact afferents and establish which plastic changes are unique to damaged nerves 
and which can also occur in the context of healthy, undamaged nerves.  Further investigation will 
be needed to elucidate the specific signaling mechanisms responsible for the changes (or lack of 
change) observed.   
Given that exogenous administration of GFLs such as GDNF and Artemin have been 
shown to sensitize cultured DRG neurons in vitro and produce acute thermal hypersensitivity in 
vivo (Malin et al., 2006), the lack of any apparent functional plasticity at the 14d timepoint, 
where Artemin and GDNF protein were significantly increased, is somewhat surprising.  In a 
CFA model of inflammation, there was not only increased expression of NGF and Artemin in the 
skin, but both TRPV1 and P2Y1 mRNA were acutely upregulated in the DRGs as well (Malin et 
al., 2006).  One potential explanation is that protein levels of Artemin and NGF are significantly 
lower in the contralateral injury model used here relative to acute inflammation.  Interestingly, 
combined injection of NGF and artemin into the skin resulted in significant thermal hyperalgesia 
lasting 6 days, several days more than what was seen when any individual factor was injected 
(Malin et al. 2006).  Also, NGF/artemin-induced hyperalgesia was significantly greater than that 
induced by artemin or NGF alone at 4 h after injection.  These data point to a potentially 
synergistic effect of trophic factor expression, possibly via potentiation of DRG targets such as 
TRPV1, in modulating the sensitivity of nociceptors in vivo.  Here, we observed cutaneous 
increases in NGF, NT-4/5, Artemin, and GDNF, suggesting that the effects of these factors way 
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work synergistically to modulate nociceptor function chronically.  The lack of acute primary 
afferent plasticity here may indicate that the levels of trophic factor expression in the 
contralateral skin, while significantly elevated, are smaller than the changes seen in injured or 
inflamed nerves but that increased trophic factors can still alter nociceptor function through the 
long-term modulation of receptor proteins and ion channel expression in the DRG.   As discussed 
earlier, single cell analysis of characterized afferents is a powerful tool that may allow us to 
directly correlate mRNA expression levels in individual sensory neurons with their response 
properties.   Such analysis would address the difficulty of detecting small changes in expression 
in a small population of cells and could reveal the trophic factor sensitivity of neurons that were 
or were not sensitized.  This avenue of investigation might also provide novel targets in the study 
of sensory neuron plasticity.  In the experiments here, for example, we might be able to 
characterize a cell’s response to thermal stimuli and then directly correlate the heat threshold or 
firing rate to the expression level of P2Y1 or TRPV1 in that neuron.  
Having shown previously (Jankowski et al., 2010, 2011, 2012) and here that siRNA 
injection can selectively block upregulation of a target gene in a localized fashion and affect 
nociceptor function, a natural question is what implications these studies may have for the 
development of therapeutic agents for persistent pain.  Though none has looked at trophic factor 
expression, several studies using experimental animals have shown that RNAi can be used to 
prevent or attenuate the development of neuropathic (Dorn et al, 2004; Dong et al., 2007; Wu et 
al., 2010; Le et al., 2011; Sun et al., 2012; Tsantoulas et al., 2012) and visceral pain (Christoph et 
al., 2006).  Trophic factors antagonists such as anti-NGF antibodies and anti-GDNF antibodies 
have both been shown to diminish inflammatory hyperalgesia and the expression of TRPV1 in 
the DRG (Amaya et al., 2004).  More recently, an anti-NGF monoclonal antibody (Tanezumab) 
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was shown in clinical trials to have a good treatment profile for osteoarthritic pain (Schnitzer et 
al., 2011; Nickel et al., 2012) and low back pain (Katz et al., 2011), but one trial was eventually 
discontinued due to accelerated joint degeneration in enrolled patients.  One of the potential 
benefits of using RNAi techniques such as the siRNA-based method used here is that it allows 
one to specifically target particular molecules in identified afferents without administration of 
systemic drugs and without inducing sub-baseline expression levels or neuronal activity.   
There are a number of obvious concerns about any approach using RNAi, however.  As 
discussed earlier, induction of RNAi in mammalian cells by expression of double-stranded RNA 
can activate innate antiviral response pathways that can produce off-target gene expression 
(Alvarez et al., 2006), even though the specific technique described here was not correlated with 
any significant activation of the interferon viral response pathway (Jankowski et al., 2009b; 
Jankowski et al. 2010).  There is also potential concern about the transient nature of the siRNA-
medicated knockdown.  Indeed we have shown that siRNA produces significant knockdown of 
P2Y1 and TRPV1 lasting 1-2 weeks after the initial injection, but the signaling mechanisms that 
are responsible for increasing P2Y1 and TRPV1, for example, may simply produce the same 
increase in expression once the siRNA’s effect passes.  Indeed our previous study showed that 
GFRα3-targeting siRNA blocked CH recruitment after regeneration and TRPV1 upregulation at 
4-6 weeks after nerve injury, but by 10 weeks, significant CH recruitment was evident, and 
TRPV1 expression had rebounded from its baseline level at 4-6 weeks (Jankowski et al., 2010). 
Clearly, engagement of the RNAi pathway has potential in the development of treatments for 
persistent pain, but identification of multiple molecular targets and engineering a means to 
deliver enough quantity of the siRNAs into the target tissue to produce significant and lasting 
knockdown without requiring repeated injections are substantial hurdles.  In the meantime, the 
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siRNA-mediated strategy we use here provides a valuable tool for investigating the role of 
transient changes in expression of specific genes in neuronal plasticity.   
 
 
 
 
 
 
 
 
 95 
APPENDIX A 
REAL-TIME RT-PCR PRIMER SEQUENCES 
Below are forward and reverse primers that were used for real-time RT-PCR experiments. 
 
From Elitt et al. (2006) 
 
GFRα3: forward, 5'-CTTGGTGACTACGAGTTGGATGTC-3'; reverse, 5'-
AGATTCATTTTCCAGGGTTTGC-3' 
 
TrkA: forward, 5'-AGAGTGGCCTCCGCTTTGT-3'; reverse, 5'-
CGCATTGGAGGACAGATTCA-3' 
 
TRPV1: forward, 5'-TTCCTGCAGAAGAGCAAGAAGC-3'; reverse, 5'-
CCCATTGTGCAGATTGAGCAT-3' 
 
TRPV2: forward, 5'-CCAGCCATTCCCTCATCAAAA-3'; reverse, 5'-
AAGTACCACAGCTGGCCCAGTA-3' 
 
TRPV3: forward, 5'-TGAAAGAAGGCATTGCCATTT-3'; reverse, 5'-
GAAACCAGGCATCTGACAGGAT-3' 
 
TRPV4: forward, 5'-TGGATTCCTTGTTCGACTACGG-3'; reverse, 5'-
CACAATGTCAAAGAGGATGGGC-3' 
 
TRPA1: forward, 5'-GCAGGTGGAACTTCATACCAACT-3'; reverse, 5'-
CACTTTGCGTAAGTACCAGAGTGG-3' 
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ASIC1: forward, 5'-CTGGACTTCCTAGTGGAGAA-3'; reverse, 5'-
CCAGCACCAGAATATTCTCC-3' 
 
ASIC2a: forward, 5'-ATGGACCTCAAGGAGAGCCCCAG-3'; reverse, 5'-
AAGTCTTGATGCCCACACTCCTGC-3' 
 
ASIC2b: forward, 5'-CGCACAACTTCTCCTCAGTGTTTAC-3'; reverse, 5'-
TTGGATGAAAGGTGGCTCAGAC-3' 
 
ASIC3: forward, 5'-ATGAAACCTCCCTCAGGACTGG-3'; reverse, 5'-
AACTCCCCATAGTAGCGAACCC-3' 
 
GAPDH: forward, 5'-ATGTGTCCGTCGTGGATCTGA-3'; reverse, 5'-
ATGCCTGCTTCACCACCTTCTT-3' 
 
 
 
From Jankowski et al. (2009): 
 
Nerve Growth Factor (NGF): forward, 5'-ACA CTC TGA TCA CTG CGT TTT TG-3'; reverse, 
5'-CCT TCT GGG ACA TTG CTA TCT GT-3' 
 
BDNF: forward, 5'-CCA TAA GGA CGC GGA CTT GT-3'; reverse, 5'-
AGGAGGCTCCAAAGGCACTT-3' 
 
NT-3: forward, 5'-CCT GTG GGT GAC CGA CAA G-3'; reverse, 5'-GAT CTC CCC CAG 
CAC TGT GA-3' 
 
NT-4/5: forward, 5'-GGA GGC ACT GGC TCT CAG AAT-3'; reverse, 5'-CCC TGG GAG TCT 
GCA GTC AA-3' 
 
Glial Cell Line Derived Neurotrophic Factor (GDNF): forward, 5'-AGC TGC CAG CCC AGA 
GAA TT-3'; reverse, 5'-GCA CCC CCG ATT TTT GC-3' 
 
Neurturin: forward, 5'-TGA GGA CGA GGT GTC CTT CCT-3'; reverse, 5'-AGC TCT TGC 
AGC GTG TGG TA-3' 
 
Artemin: forward, 5'-GGC CAA CCC TAG CTG TTC T-3'; reverse, 5'-TGG GTC CAG GGA 
AGC TT-3' 
 
p75: forward, 5'-GGG TGA TGG CAA CCT CTA CAG T-3';reverse, 5'-GTG TCA CCA TTG 
AGC AGC TTC T-3' 
 
trkB: forward, 5'-GCT GAT GGC AGA GGG TAA CC-3'; reverse, 5'-GCG ATT TGC TGA 
GCG ATG T-3' 
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trkC: forward, 5'-GCT TTC CAA CAC GGA GGT CAT-3'; reverse, 5'-GCA GAC TCT GGG 
TCT CTC CAA-3'  
 
GFRα1: forward, 5'-GTG TGC AGA TGC TGT GGA CTA G-3'; reverse, 5'-TTC AGT GCT 
TCA CAC GCA CTT G-3' 
 
GFRα2: forward, 5'-TGA CGG AGG GTG AGG AGT TCT-3'; reverse, 5'-GAG AGG CGG 
GAG GTC ACA G-3' 
 
P2X3: forward, 5'-TGG AGA ATG GCA GCG AGT A-3'; reverse, 5'-ACC AGC ACA TCA 
AAG CGG A-3' 
 
P2Y1: forward, 5'-GGC TAT CTG GAT GTT CGT TTT CC-3'; reverse, 5'-CCA GAG CCA 
AAT TGA ACA TGT ACA-3' 
 
P2Y2: forward, 5'-TTG GCA GGG GCT CAG GA-3'; reverse, 5'-GCA TAG GAG TCG GGT 
GCA-3' 
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